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Abstract
Asthma and Chronic Obstructive Pulmonary Disease are chronic and long-term lung
diseases. Disease monitoring with minimal sensors with enough efficacy can make the disease
management easier and efficacious for patients. Towards this goal, we propose a new model for
the severity assessment of these diseases through wearables and compatible with mobile health
applications, using only peripheral capillary oxygen saturation (SpO2) and heart rate (from pulse
oximeter sensor). Patient data are obtained from the MIMIC-III Waveform Database Matched
Subset. The dataset consists of 168 subjects. Both heart rate signal and SpO2 data of subjects are
analyzed in retrospective via the proposed model to classify the severity of the diseases.
Strategically, a rule-based threshold approach in real time evaluation is considered for the
categorization scheme. Furthermore, a method is proposed to estimate severity as an Event of
Interest (EOI) using the computed metrics from the datasets of the subjects with mathematical
functions. Finally, four hyper-parameter models and K-Means Clustering algorithms are
implemented for the distributions of severities of the diseases. For asthma, maximum accuracy is
60% and sensitivity is 78%, while the achieved maximum accuracy for COPD is 76% but the
sensitivity is 45%. This type of autonomous system for real-time evaluation of patient’s
condition has the potential to improve individual health through continual monitoring and selfmanagement, as well as improve the health status of the overall Smart and Connected
Community (SCC).
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I.

INTRODUCTION

Asthma and Chronic Obstructive Pulmonary Disease (COPD) are characterized by
respiratory symptoms due to airflow limitations and alveolar abnormalities in the presence of
significant exposure to gas or noxious particles. Chronic Obstructive Pulmonary Disease is
currently the fourth most prevalent cause of death in the world and it is projected to be the third
leading cause of death by 2020 [1]. Asthma and COPD are leading causes of morbidity and
mortality that include economic and social burden. In the USA and European Union, COPD
management suffers from 32 billion dollars and 38.6 billion Euros loss, respectively [1].
A.

Significance

Asthma and chronic pulmonary diseases need continuous attention and care to control the
diseases. With the advent of telemonitoring, real-time data used for the assessment of the
condition of the diseases, the patient can check their disease without wasting time in an
unnecessary and regular visit to the hospital. Hence, continuous real-time monitoring of the
disease condition might aid the patient to improve their health, as well as improve the health
status of the Smart and Connected Community (SCC).
Managing asthma and chronic obstructive pulmonary disease (COPD) at home have
immense potential to progress in healthcare. At home measurements of severities of the chronic
diseases by telehealth technologies enables effective self-management and can reduce sudden
deterioration.
The proposed solution can provide immediate feedback to the patient for self-awareness
of the disease and sharing of the severity score with other community members can lead to an
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improvement of overall community health towards a Smart and Connected Community (SCC). A
SCC aims to use embedded sensors and computing for greater benefit to individuals, the
community, and society with interlocking physical, social, behavioral, economic, and
infrastructural challenges. Ability to detect and monitor progression of COPD and asthma using
physiological data such as heart rate and peripheral capillary oxygen saturation (SpO2) from
wearables can lead to better self-management and improved overall health of SSC. Thus, the
proposed model has the potential for real-time monitoring at home with wearables for SCC.
B.

Methods

The goal of the work is to develop models, then to select the best predictive model and to
compare the severity groups with clustering of the diseases. In this work, heart rate and SpO2
data are used in retrospective manner from the open-access MIMIC III database. The number of
COPD, asthma, and healthy subjects collected from MIMIC III databases are 168. Time series
signals and principal components are explored as predictive features from the heart rate and
SpO2 collected via a pulse oximeter. Severity estimation algorithms are built with mathematical
functions and are analyzed for best performance.
In this work, the primary focus is to classify the disease from normal to severe with the
help of a rule-based algorithm by analyzing time series signals captured using minimal sensors.
In clinical practices, pathologic feature heart rate and SpO2 are used to measure the exacerbation
of both diseases. Events of Interest (EOI) score is proposed to calculate as the severity of both
asthma and COPD individually by using the peripheral oxygen saturation and heart rate signals
simulated from the pulse oximeter. Then, based on the EOI score, five distinct stages are
categorized according to the Global Initiative for Chronic Obstructive Disease (GOLD) and the

2

Global Initiative for Asthma (GINA) guidelines [1-2]. Lastly, selected hyper-parameter models
and K Means Clustering algorithms are compared for the distributions of severities of the
diseases. The GOLD and GINA severity stages for COPD and asthma subjects respectively are
classified by the severity models proposed here.
C.
•

Key Results

Asthma subjects have greater numbers of heart rate in severe minutes compared to COPD
subjects heart rate number of minutes in severe stages.

•

Oxygen saturation distribution shows no significant differences among the subject
groups.

•

After comparing four hyperparameter combinations, the cubic models show greater mean
EOI over the tangent models, comparable results are observed during validation also.

•

Accuracy: 76, Sensitivity: 45 and Accuracy: 60, Sensitivity: 78 are achieved with the
tangent models for COPD and asthma, respectively.

•

The number of subjects in the different Severity zones (0 to 4) are 15, 28, 14, 6 and 4,
respectively, by the αTMβE Model in the asthma distribution, while for COPD, the
distribution for Severity (0 to 4) by αTMβU are 47, 25, 5, 4 and 4, respectively.

•

By the alternate k means clusters Severity (0 to 4) are 43, 17, 4, 17 and 4, respectively,
for COPD, while for asthma, the distribution for severity (0 to 4) are 17, 10, 28, 4, and 8,
respectively.

•

Finally, for Severity (0 to 4), the exact assignments of groups are 22, 6, 1, 1 and 0 for
COPD and 12, 8, 12, 0, and 3 for asthma, respectively.
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II.

LITERATURE REVIEW

Methods for objective identification of disease severities may focus on clinical
interventions and help find effective medication pathways. Few studies have explored severities
by observing physiological signals. Sanchez-Morillo et al. suggested the scope for early
detection of the severity of both COPD and asthma by different learning methods based on
clinical measurements from various sensors [3].
A.

Guidelines

When a patient experiences worsening of the disease condition, this is called an
exacerbation or flare-up. The European Respiratory Society and American Thoracic Society
Task Force considered asthma severity into mild, moderate, and severe groups excluding
uncontrolled and refractory asthma based on pulmonary function tests along with treatments [2].
However, all the groups are labeled as persistent and a different intermittent mild group is
suggested in the thorough review on different categorization done by Jacob, Christian, et al. [4].
Vestbo, Jørgen, et al. summarized the GOLD guideline and gave an overview of the key
points. They have discussed that spirometry only confirms the persistent airflow limitations, but
considerable evidence presents that FEV1 is a poor descriptor to the disease status. So, there is a
scope of improvement in the management of stable COPD [5].
B.

COPD Related Literature

In the study conducted by Christos C. Bellos et al. several sensors have been used for
various parameters such as heart rate, systolic and diastolic pressure, oxygen saturation (SpO2),
respiratory frequency, inspiratory and expiratory time, and tidal volume and they have presented
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a hybrid classification system with Support Vector Machine and Random Forest [6]. The severity
of COPD was classified according to both clinician’s labeling and GOLD guidelines [1].
According to the GOLD guidelines, the severity of the patients with COPD is labeled in four
classes according to the Forced Expiratory volume in 1 second (FEV1) values [1]. However, by
reducing the number of sensors for the prediction of COPD exacerbations, another group of
researchers considered heart rate, oxygen saturation, and respiration rate as the three vital signs
for the input to the logistic regression classifier [7]. Alternatively, a decision support system with
threshold has been adapted to detect the exacerbation with heart rate and oxygen saturation by a
group of researchers [8].
Another study focused on the risk of exacerbation results by the Classification and
Regression Tree (CART) classifier, which depends on a few sensor measurements: Forced
Expiratory Volume in One Second (FEV1), respiratory rate, oxygen saturation, heart rate, body
weight, and body temperature [9]. Current pathological state of the art for severity of both
diseases are the spirometry (FEV1) value. However, these devices need maximal effort and
collaboration from the patient side, which makes the scope of the noninvasive technologies to
maximize the comfort. Al Rajeh et al. discussed the literature of COPD severity detection based
on pulse oximetry in [10]. Heart rate and SpO2 values are independent and no significant
correlation was found during stable periods and periods with severe COPD exacerbation [11].
Burton C et al., examined the association between Physiological measurements (oxygen
saturation (SpO2), forced expiratory volume in one second (FEV1) and pulse rate) and total
symptom score forming questions about cardinal symptoms of an exacerbation using multilevel
logistic regression. In their study they also discussed about the patterns of exacerbation [12].
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The research by van der Heijden, Maarten et al. described a probabilistic model
delivering autonomous aid in disease management predicting exacerbation. Probabilities of an
exacerbation were calculated from the joint probability distributions with the support of a
Bayesian network and expert knowledge model [13]. Jensen, Morten H., et al. monitored mean,
standard deviation, kurtosis, skewness and linear regression of blood pressure, heart rate, oxygen
saturation (SpO2), FEV1 and body weight and classified episodes by linear discriminant
classifier to treat prediction of exacerbations by as a pattern recognition problem [14]. Pinnock,
Hilary, et al. proposed thresholds for symptom score and oxygen saturation which alerted clinical
monitoring team to contact the patient and evaluate the system with a control group without the
setup [15]. Oxygen saturation, heart rate, body temperature, and physical activities are watched
and achieved lower number of exacerbations in the research by Pedone, Claudio, et al [16].
J. Cruz et al., reviewed the methodologies or the types of technologies for COPD
telemonitoring for the patients’ satisfaction and difficulties and mentioned most patients reported
satisfactions [17]. In another review work, Cruz, J., D. Brooks, and A. Marques., discussed the
effectiveness and telemonitoring and they found the worsening of oxygen saturation as the most
altered clinical finding [18].
C.

Asthma Related Literature

Amaral, Jorge LM, et al. investigated the forced oscillation technique (FOT) in the
diagnosis of airway obstruction with supervised machine learning (ML) techniques, including knearest neighbors (KNN), random forest (RF), AdaBoost with decision trees (ADAB) and
feature-based dissimilarity space classifier (FDSC) [19]. Among them ADAB and KNN were
very close to achieving high accuracy, AUC 0.88 and 0.89 respectively. After Experimenting the
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cross products of the FOT parameters all the classifiers showed improvement in the diagnosis
accuracy and KNN was able to reach a highest accuracy among them [19].
Bang, Seo-Jin, and Wei Wu. partitioned 378 subjects with and without asthma into 6
clusters based on 112 variables which encompassed a wide range of characteristics including
clinical, physiologic, and inflammatory variables. cluster labels, then used naïve Bayes ensemble
for test datasets [20]. The same group of researchers previously proposed a feature choice
framework based on information-theory involves ranking features using a correlation
measurement information gain (called INFOGAIN), and then selecting relevant, nonredundant
features using a Markov blanket algorithm. They have applied a k-means clustering method to
the preprocessed data to partition the subjects including normal controls (NCs) and a Ward’s
agglomerative hierarchical clustering method to the preprocessed data grouped clinical variables
[21].
Finkelstein, Joseph measured peak expiratory flow (PEF), symptoms, self-reported
medication consumption, and asthma trigger exposure on a skewed dataset which leaded to lower
sensitivity using the minimum description length (MDL) principle on a naïve Bayesian classifier,
adaptive Bayesian network, and support vector machines to predict asthma exacerbation
occurring on day different time windows [22].
Brasier, Allan R., et al. found four groups of asthmatic profiles to discriminate asthma
phenotypes on the basis of cytokine profiles in bronchoalveolar lavage (BAL) samples from
patients on the basis of unsupervised analysis (hierarchical clustering) [23].
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Arnold, Donald H., Cathy A. Jenkins, and Tina V. Hartert. proposed area changes of
pulsus paradox, a physiological phenomenon of (an abnormally large decrease in systolic blood
pressure) as compared to FEV1 for the asthma severity assessment [24].
Melbye, Hasse, Salwan Al-ani, and Mark Spigt. predicted the change of FEV1 by
increased wheezing and a decreased SpO2 in linear regression for patients diagnosed with asthma
or COPD [25]. Dalbak LG, Straand J, Melbye H. bolstered pulse oximetry association with
FEV1 and explored predicted FEV1 less than 50% as the strongest predictor among age,
comorbidity with coronary heart disease, decreased FEV1% predicted, and hemoglobin above
normal for the prediction of SpO2 less than 95% by multivariate logistic regression [26].
Established combinations of models for COPD and asthma, and measurement of the
classification performances for different models and parameters are assessed [27]. The COPD
and asthma populations’ distributions are compared with K-means clustering to set up correct
model representations [28]. In Table I several features and algorithms are described for the ease
of accumulation of information in the existing literatures.
TABLE I.
Se No

Year,

DESCRIPTIONS OF FEATURES AND ALGORITHMS

Parameter

Features

Algorithm

Efficiency

2016,

SpO2

Selected: Mean Logistic

Prediction

Shah [7]

RR

Compared: SD, Regression,

AUC: 0.682

HR

Y intercept

Author
1.

SVM, KNN,
DT
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TABLE I.
2.

DESCRIPTIONS OF FEATURES AND ALGORITHMS (CONTINUED)

2016,

SpO2

Mean

Decision

Merone

HR

SD

Support System Accuracy:

[8]

Detection,

Score

98.4%

generation

Sensitivity:
99.3, F1 Score:
94

3.

2014, C.

SpO2

Mean

SVM

Bellos [6]

Heart Rate

SD

Random forest

Breathing Rate

gain ratio

trees

Blood Pressure

attribute

temperature

evaluation

CO2

(Gain)

Peak flow

Correlation

Accuracy 94%

based
feature subset
selection (CFS)
4.

2015,

FEV1

Raw value

Mohktar

SpO2

Mean, SD

[9]

RR, HR

percentage

Temperature

change

Weight

Z-Score

11

Decision trees

Prediction

TABLE I.
5.

DESCRIPTIONS OF FEATURES AND ALGORITHMS (CONTINUED)

2011,

BP

Mean

Linear

Sensitivity

Jensen

HR

SD

Discriminant

70%

[14]

SpO2

Skewness

Specificity

Kurtosis

95%

Linear

AUC 0.73

Regression
6.

7.

2015,

HR

Change in raw

Multilevel

Burton

SpO2

data

Logistic

[12]

FEV1

Mean

Regression

2013,

SpO2

Normal or

Bayesian

Heijden

FEV1

abnormal

Network
Expectation

[13]

Maximization

12

Odds ratio

AUC 0.87

III.

METHODS

The method for severity calculation can be divided into six steps. Typically, the data is
collected from the wearable sensors, but in this retrospective study, we have used a database that
has various sensor data collected from patients. Fig. 1 graphically shows the steps, which are
briefly described below.

Data Collection: MIMIC & other Databases
Data Processing: Mean Imputation
Feature Extraction: Time (Minutes) and PCA
Model Selection: α, β, and EOI Calculation
Classification and Validation: 4 Models and K-Means Clustering
Severity Results: Distributions and Statistical Performance Analysis

Figure 1: Flowchart of the process for asthma and COPD severity level detection.
A.

Data Collection

The heart rate and oxygen saturation values were processed from the
photoplethysmogram signal captured by the pulse oximeter. Pulse oximeters are noninvasive
portable medical devices, these wearables are easily adaptable both in and out of hospital setting
environments. If a continuous monitoring is available like in hospital that will fit the proposed
method. Otherwise, measuring daily data from the pulse oximeter and processing by scanner or
mobile app during real data collection will be helpful. For the missing days data due to
forgetfulness or low battery or any other unavailability, the missing data are attributed to linear
assumptions in a piecewise manner in the algorithm.
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Although the datasets used here are collected from ICU patients, the algorithm can be
applicable for both patients at home and hospital. The data collection procedure for this
algorithm is very flexible and robust. For our study, the sensor data are collected directly from
the database. Data might need to be resampled based on the algorithm or processing technique. If
the algorithm uses multiple signals at a different sampling rate, they need to be resampled to a
common sampling rate. In our case, we have used the dataset with one sample per minute.
B. Datasets Description
All the datasets used in this study are from large collections of recorded physiologic
signals (Physio Bank) and publicly available databases from PhysioNet [29]. The total number of
patients is 168, where 85 have COPD, 67 have asthma, and 16 are healthy subjects as the control
group.
For asthma datasets, 5 subjects are collected from the MIMIC-II Waveform Database
[30] and the other 62 subjects are taken from the closely related, recently released MIMIC-III
Waveform Database Matched Subset [31], both the databases are downloaded from the free web
access on PhysioNet. The subjects selected from the MIMIC-III are according to the
International Classification of Diseases (ICD9) code 493 and only labeled 1 for the sequence
number or the order of treatment. For COPD, all 85 subjects are from MIMIC-III Matched
Waveform Dataset, according to their ICD9 code 496, and treatment order labeled as 1 or 2.
There is no clinical or machine annotation available to label the patient condition and all subjects
are in intensive care unit during the data collection in both the Mimic databases.
Healthy control groups are available from two separate databases; 5 subjects are from the
CAP sleep database [32] and one healthy subject is from ECG sleep apnea database [33], all are
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downloaded from Physiobank web access. The total duration of the pulse oximeter signals is 3
minutes long and much less than the duration of the signals collected for the subjects from the
MIMIC databases. For ECG sleep apnea database, the heart rate signal is calculated from the
given RR interval of the ECG signal. The rest 10 healthy subjects are extracted from Sleep
Health Database [26-34].
TABLE II.

DESCRIPTIONS OF DATABASES AND DATASETS

Subject

Sample Size

COPD

85

Database

Description

MIMIC-III Waveform

Treatment Order: 1

Database Matched Subset

and 2

MIMIC-II Waveform
Database (5)
Asthma

67

MIMIC-III Waveform
Database Matched Subset Order of Treatment: 1
(62)
Sleep Health Database
(10)

Healthy Control

16

CAP sleep database (5)
ECG sleep apnea
database (1)
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The total numbers are under the sample size column and the numbers of exact subjects
from each individual dataset are shown in the parentheses with the name of the corresponding
datasets, in Table II. All the databases used here for the data collection are labeled as Class 3,
standing for other contributed collections of data, including works in progress.
C. Data Processing
Missing values or abnormal readings are common occurrences in datasets. For heart rate
signal, values outside 40 and 200 bpm can be considered as improbable, and for oxygen
saturation, values between 20 and 100 are taken into consideration [12]. Several approaches can
be applied to compensate for the missing data prior to further processing for meaningful
interpretation.
Christos C. Bellos et al. investigated list wise detection, mean/mode imputation, K-nearest
neighbor estimation to take care of the missing values [6]. On the other hand, Burton et al. simply
ignored the missing values in his work [12]. In this study, the mean is imputed by a continuous
linear interpolation of neighboring, non-missing values. The missing values are inserted from one
non-missing value to the next non-missing value as calculating them using the piecewise linear
method. The linearly calculated mean is imputed during the data processing. In Fig. 2, the raw
signal and processed signal for both heart rate and oxygen saturation are shown after this
processing step.
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Figure 2: Raw and processed data for Heart Rate and SpO2.
D. Feature Extraction
The mean and the standard deviation of heart rate and oxygen saturation are the features in
the study of decision support system [8]. For Mokhtar et al. distribution mean, standard deviation,
the percentage change of the parameter from the distributed mean and the standard score or zscore are the features [9]. In this study for the proposed rule, features extracted from two types of
physiological measurements are the percentage of the total duration of labeled minutes in each
parameter.
To extract the features, the signals are divided into five zones based on threshold values
like GOLD stages [6]. For heart rate, the gold classes are 0 for < 90, 1 for 90-100, 2 for 100 – 110,
3 for 110 – 120 and stage 4 is greater than 120 beats per minutes [6]. For peripheral oxygen
saturation value, greater than 92% is considered as normal, for GOLD stage 1 it is 90% - 92%,
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and for GOLD stage 4, the value is considered less than 80%. The GOLD stages 2 and 3 are
differentiated by the clinicians based on the presence of only room air or external O2 supply [6].
TABLE III.

EXTRACTED FEATURES FOR MODELING

Category

Features

1. Sev-0 Normal (NOR)

Heart Rate Value

2. Sev-1 Mild (MIL)

Heart Rate Value

3. Sev-2 Moderate (MOD)

Heart Rate Value

4. Sev-3 Severe (SEV)

Heart Rate Value

5. Sev-4 Very Severe (VES)

Heart Rate Value

Category

Features

1. Sev-0 Normal (NOR)

SpO2 Value

2. Sev-1 Mild (MIL)

SpO2 Value

3. Sev-2 Moderate (MOD)

SpO2 Value

4. Sev-3 Severe (SEV)

SpO2 Value

5. Sev-4 Very Severe (VES)

SpO2 Value
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In this current study, stages 2 and 3 are assumed as between 85% - 90% and 80% - 85%.
However, for asthma exacerbations management heart rate 100 -120 bpm, SpO2 90 -95% and
greater than 120 bpm, less than 90% has been used for mild or moderate and severe asthma
respectively in GINA guidelines [2]. The processed signal on the right-hand side In Fig. 2, both
heart rate and oxygen saturation signals are labeled as Normal (Severity-0), Mild (Severity-1),
Moderate (Severity-2), Severe (Severity-3), and Very severe (Severity-4) minutes.
After dividing the total duration of the signal into the total minutes spent in each severity
level, the five levels and the percentage distribution of the total minutes of the five levels are
calculated. The five different percentages of minutes of each signal (ti) are the features extracted
for the algorithm shown in the Table III. Among all the healthy subjects for the control group only
one have minutes in the mild GOLD Stage 1 and for other control subjects, there is no variation in
the oxygen saturation in the physiological signals obtained from the database.

Heart Rate

α Model

EOIHR
β Model

SpO2

α Model

EOISpO2

Figure 3: Modeling of asthma and COPD for severity detection.
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EOI

E. EOI Calculation
The severity is computed as Events of Interest (EOI) [37] from the extracted features from
the ten different percentages of minutes HRi and SpO2i. EOIHR and EOISpO2 values are calculated
with αi.
In Equation 1, the proposed linear equations to calculate the severity are given. α is
multiplied by minutes spent in the corresponding stages (ti) for the heart rate (HR) and oxygen
saturation individually. At first, the EOI is calculated separately for heart rate (EOIHR) and oxygen
saturation (EOISpO2). Then, the joint EOI (EOI) is calculated by multiplying both EOIs with their
corresponding weight (β HR:β SpO2) and then overall EOI values are found for COPD (EOIC) and
for asthma (EOIA). Finally, EOIN values are normalized to 100 for both COPD (𝐸𝐸𝐸𝐸𝐸𝐸𝑁𝑁𝐶𝐶 ) and asthma
(𝐸𝐸𝐸𝐸𝐸𝐸𝑁𝑁𝐴𝐴 ) in different scales.

EOIHR = ∑4𝑖𝑖=0 𝛼𝛼𝑖𝑖 ∗ 𝐻𝐻𝐻𝐻𝑖𝑖

EOISpO2 = ∑4𝑖𝑖=0 𝛼𝛼𝑖𝑖 ∗ 𝑆𝑆𝑆𝑆𝑆𝑆2 𝑖𝑖

𝐶𝐶
𝐶𝐶
EOIC=𝛽𝛽𝐻𝐻𝐻𝐻
∗ 𝐸𝐸𝐸𝐸𝐸𝐸𝐻𝐻𝐻𝐻 + 𝛽𝛽𝑆𝑆𝑆𝑆𝑆𝑆2
∗ 𝐸𝐸𝐸𝐸𝐸𝐸𝑆𝑆𝑆𝑆𝑆𝑆2

𝐸𝐸𝐸𝐸𝐸𝐸𝑁𝑁𝐶𝐶 =

𝐶𝐶
𝐸𝐸𝐸𝐸𝐸𝐸 𝐶𝐶 − 𝐸𝐸𝑀𝑀𝑀𝑀𝑀𝑀

𝐶𝐶
𝐶𝐶
𝐸𝐸𝑀𝑀𝑀𝑀𝑀𝑀
− 𝐸𝐸𝑀𝑀𝑀𝑀𝑀𝑀

𝐴𝐴
𝐴𝐴
EOIA =𝛽𝛽𝐻𝐻𝐻𝐻
∗ 𝐸𝐸𝐸𝐸𝐸𝐸𝐻𝐻𝐻𝐻 + 𝛽𝛽𝑆𝑆𝑆𝑆𝑆𝑆2
∗ 𝐸𝐸𝐸𝐸𝐸𝐸𝑆𝑆𝑆𝑆𝑆𝑆2

𝐸𝐸𝐸𝐸𝐸𝐸𝑁𝑁𝐴𝐴 =

𝐴𝐴
𝐸𝐸𝐸𝐸𝐸𝐸 𝐴𝐴 − 𝐸𝐸𝑀𝑀𝑀𝑀𝑀𝑀

𝐴𝐴
𝐴𝐴
𝐸𝐸𝑀𝑀𝑀𝑀𝑀𝑀
− 𝐸𝐸𝑀𝑀𝑀𝑀𝑀𝑀

αi = Weightage for Heart Rate (HR) or SpO2 in stage i.
HRi = Percentage of minutes for Heart Rate in stage i.
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(1)

SpO2i = Percentage of minutes for SpO2 in stage i.
β HR = Weightage for Heart Rate.
β SpO2 = Weightage for SpO2.
EMIN = the smallest value for variable EOI.
EMAX = the largest value for variable EOI.
Heart rate and SpO2 makes the joint probability distribution and they are independent [11].
For all the values of Heart rate SpO2, the model will generate a score. The final EOI values are a
joint value of heart rate and oxygen saturation. These linear relationships are well suited for
generalization and avoid overfitting the data. Bronchial asthma and COPD are different diseases,
but they share similar symptoms, so the EOI of these diseases are calculated on different scales.
F. Model Selection
The environment is partially observable as the severity and the other diseases are not
known to the agent completely. In this situation, a model based reflex agent will effectively deal
with the situation with a knowledge of internal state or predefined functions to model the world
for the agent [38]. For the random variable α, the severities are the conditions and in the domain
and different with situations as conditioning are given to that domain of severity [38]. All the
mathematical functions for α are scaled after averaging and dividing by the sum to make the
probability destiny function works at unity.
To develop a robust and generalized algorithm which can generate a score for the modelbased approach is explored by simple linear functions described in Table IV to make the
mathematical model of the EOI. For Normal, it is expected to have low value, for Mild to Severe
gradually increased weight, and for Very severe is expected to have greater value. The
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trigonometric, algebraic, and exponential functions are modeled for α. The functions are averaged
and scaled to corresponding percentage values to compare and make on a fixed scale.
TABLE IV.

Models

MATHEMATICAL FUNCTIONS FOR α MODEL

α Values

Description

Cubic (CM)

23, 33, 43, 53, 63

[1.82, 6.14, 14.55, 28.41 49.1]

Exponential (EM)

e2, e3, e4, e5, e6

[1.17,3.17,8.61, 23.41, 63.64]

Square root (SM)

√0.01,√0.1,√1,√10,√100

[0.69,2.17,6.86, 21.69, 68.59]

Four Power (FM)

42, 43, 44, 45, 46

[0.29,1.17,4.69, 18.77, 75.07]

Power Ten (PM)

210, 310, 410, 510, 610

[0.02,0.08,1.47, 13.69, 84.76]

Inverse Tenth (IM)

0.01, 0.1, 1, 10, 100

[0.009, 0.09, 0.9, 9, 90]

tan(1°), tan(22.5°), tan(45°),
Tangent (TM)

[0.03, 0.68, 1.64, 3.95, 93.71]
tan(67.5°), tan(89°)

During modeling, two hyperparameters α and β are explored to represent the models. For
the α modeling, Severity 0 is expected to have the smallest values and all the other severities
should have significant weight increased proportionally to their intensity. In Table IV, total seven
mathematical functions and their corresponding weights for the distinct severities are tabulated. In
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the Fig. 4 the percentage weights after scaling are plotted. Finally, as the tangent model stands for
the sharpest rise and cubic model stands for the most gradual rise, both models are selected for
comparison.

Figure 4. The α plot as Percentage and for various levels of severities.
Graphs of functions used in the analysis of models, showing the Percentage α versus input
severity for each function. β is the ratio of the weights for heart rate and SpO2. Heart rate and
SpO2 ratios are named 50: 50 as βE, 40: 60 as βU, 20: 80 as βO and they are compared in Figure 5.
COPD is in the 1st row and asthma is in the 2nd row. The lines are the fitted curve with 1 degree of
freedom. For each subject, the x-axis stands for the calculated EOI score for an individual model,
while y-axis depicts the corresponding percentage of minutes in each severity. The lines are
showing the relationship between the EOI score and the features or the percentage of minutes.
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The columns are severity 0 and Severity 4 to depict their relationships with the β values. The rest
of the severities (1-3), are similar for all β. So, β is selected from the two extreme severities.
The relationship of EOI with severity 0 and severity 4 are expected to be inversely proportional
and proportional respectively. But for βO the expected relationships are not found. So, for final
model selections β choice is limited to βE and βU.

Figure 5. The β plot as for various levels of severities.
G. Classification
The clinical course of bronchial asthma and COPD differ so their severity groups are
labeled according to the GINA [2] and GOLD [1] guidelines respectively. Based on the EOI for
COPD, asthma, and healthy control groups, the stages are linearly separated into five separate
groups. For severity 0 classification the threshold for healthy to patient EOI of 0-1 is taken. Then
for severity 1 EOI is 2-9, severity 2 EOI is 10-19, severity 3 EOI is 20-49, and severity 4 EOI is
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50-100 are used to calculate the distinct severities. The higher EOI values are prone to
exacerbation and are probable to deal with hospital admissions.
H. Severity Results
The Performance evaluation criteria select the best model based on the generalization
capability. Some of the known and used often for results are accuracy, the area under the receiver
operating characteristic (ROC) curve i.e. (AUC), sensitivity, specificity, harmonic mean (F1
Score), precision, positive predictive value, and negative predictive value. Usually, in medical
diagnosis sensitivity, specificity and AUC are reported as their performances.
I.

Validation

PCA and K means clustering algorithms are implemented to take an approach of
validating the result. K means are not full confident analysis because this is based on unlabeled
data. But an approach to check and confirm the results has been explored here.
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Figure 6: Proportion of variances explained (PVE) for principal components.
Another set of features are the principal components of all the ten features taken from the
signals. In Fig. 6, the proportion of the variances explained (PVE) captured after each principal
component is sketched. From the cumulative PVE, more than 80% variance of all the 10 features
is within the first 3 components. For the five severities, 5 clusters are formed by the K-Means
clustering. For cluster visualization, the principal components 1 and 2 are taken. Finally, the
selected model and K-Means Clustering classification algorithms’ results are compared to see the
agreements between them.
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IV.
A.

RESULTS

Statistical Distributions

COPD, asthma, and healthy control groups showed the different percentage of time
duration at various severity level for both signals. In Fig. 7, a representative distribution of the
percentage of the duration for heart rate and SpO2 signal are shown for subjects of the three
groups. For COPD patients, heart rate signal is in normal zone for 47% of the total duration. The
other zones for heart rate are 23%, 22%, 4%, and 3% from low to high severe minutes. Similarly,
SpO2 of the COPD is in the normal zone for 61% of the total duration spent.

Figure 7: Percentage distribution of Severity for both Heart Rate and SpO2.
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In Fig. 8 and Fig. 9 the median is shown along with the 25th and 75th percentiles as box
plots. To compare the total dataset statistics, the median distribution of the percentage of total
minutes are compared among the three groups. For the oxygen saturation, the median value in the
severity 0 for the COPD is slightly more than asthma normally spent time. For both diseases, the
1st quartile and 3rd quartile are very close to the median values. For the severe minutes, oxygen
saturation shows a similar percentage of minutes for both diseases.
Considering heart rate, Fig. 8 shows median of severity 0 is more than 80% for COPD, for
asthma the median is much smaller and only above 40%. So, for the asthma subject group, they
tend to spend most of the times in severity 1-3 minutes. Also, the 1st quartile and 3rd quartile are a
distance from the median, shows a greater variety of the population’s heart rate values. For the
patient subjects, as severity 0 level shows differences, the median of the percent minute for COPD
is always greater than that of the asthma subjects in the severe minutes except for the severity 4.
For the control group, the normal minutes are 100% and severe minutes are almost null.
Also, the healthy control group passed always normal heart rate and SpO2 condition. For
the mild Severity, 1 healthy HR has outliers and subjects at different zones are also shown as the
outliers.
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Figure 8. Box plot for Percentage of minutes for distinct levels of Peripheral Oxygen
Saturation (SpO2).

Figure 9. Box plot for Percentage of minutes for different levels of Heart Rate.
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TABLE V.

SPO2 (%)

HEART RATE AND SPO2 OF THE STUDIED GROUP

SUBJECTS

SEV-0

SEV-1

SEV-2

SEV-3

SEV-4

COPD

86.95±18.29

4.45±4.67

3.14±4.81

1.13±2.25

4.33±13.29

ASTHMA

89.88±15.92

4.58±7.14

2.82±6.15

1.12±3.18

1.61±5.75

HEALTHY

100

0

0

0

0

2.65±6.16

1.96±6.91

COPD

72.59±30.89 15.22±16.98 7.58±11.62

HEART
ASTHMA

48.47±35.14 17.86±16.04 16.48±17.9 9.98±15.52 7.21±14.35

RATE (BPM)
HEALTHY

97.5±6.12

2.5±6.12

0

0

0

Values are presented as mean ± standard deviation.
Table V describes the total mean and standard deviation values for heart rate and SpO2
among the COPD and asthma subjects.
B.

Percentage Distributions by Models

Four different models consisted of combinations of two different α and β values are
selected and compared in the Fig. 10 and 11 to choose the generalized model by their relationship
with EOI values. For the total samples, Fig. 10 depicts the mean and the standard deviation for all
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the subjects in the datasets. By only taking equal ratios (Heart Rate: SpO2-50:50, βE), asthma
subjects showed greater EOI in compared to taking the same models and unequal ratios (Heart
Rate: SpO2-40:60, βU). The overall EOI for asthma and COPD mean for same β values the cubic
model (αCM) showed greater mean compared to tangent model (αΤM).

Figure 10. Mean EOI plots of four selected models for COPD, asthma, and healthy.
The 1st row stands for COPD and the 2nd row for asthma in Fig. 11. The lines are the fitted
curve with 1 degree of freedom. The x-axis is the calculated EOI score for each model and along
the y-axis for each subject, the corresponding percentage of minutes in each severity is drawn.
The lines are showing the relationship between the EOI score and the features or the percentage of
minutes. The columns are for different severities. For COPD, SpO2 Severity 0 and 4 gives best
results with αTMβU, changes the most with increasing EOI. But for the other severities, αCMβU
performs the best. In case of heart rate in the severity 0 the αCMβU and αCMβE curve penalize the
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most. The cubic model (αCM), the equal beta (βE) has the sharpest inverse ratio with the increasing
EOI value. For the Severity 4, all the models give a similar relationship with EOI. So, αCMβE
performs well here. But, αCMβU does not fit SpO2 in any way. So, βU is chosen for COPD models.
Considering higher priorities to the severity 4, αTMβU is finally selected for severities
classification for COPD. For COPD, SpO2 has shown greater predictability [8], so β value taken
to use oxygen saturation with slightly greater weight goes with it.
For asthma, the β dominates the decision a lot. The severities 0-3 the cubic model αCMβE
shows a directly proportional relationship while the αTM shows the inversely proportional
relationship in case of heart rate. So, for heart rate, the cubic model is selected. In case of the
SpO2, the αTMβU and αCMβU in the severity 0 are mostly penalized, the αTMβU of the severity 4
stands for a maximum. According to the observations, Severity 1-4 are important and the best
performer among the four is considered to represent the characters of α and β well. For SpO2
severity 4, αTMβE performs best. Again, for priorities to the severe 4, αTMβU is selected for
asthma.
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Figure 11. EOI plots of four selected models for COPD, asthma, and healthy.
The subjects from Fig. 7 for COPD, asthma, and healthy control groups are shown with their
calculated EOI values in Fig. 12. As the asthma subject spends in severe minutes for a long time, so the
EOI value reflects higher scores. The healthy subjects have the least EOI values and the EOI score differs
slightly for the four models.

Figure 12. EOI validation plots for sample COPD, asthma, and healthy.
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C.

Performances

The main aim of this study is to make models to classify different severities for the diseases, but
the severities of the subjects are not labeled in the datasets. So, the performances of the models are
measured based on calculating the accuracy, sensitivity, and area under the curve to distinguish the
subjects from healthy to patients. As information is available for the distinct groups. In table VI, the four
models are compared according to their performances to distinguish between healthy and patients. The
best AUC for COPD is 0.76, for asthma 0.6. The accuracy is always equaled to the AUC here. In a
qualitive manner the results are drawn in the Figure 13 and Figure 14.
TABLE VI.

THE AREA UNDER THE ROC CURVE (AUC), THE STANDARD ERROR (SE), AND
SENSITIVITY
PERFORMANCE METRICS (%)

SUBJECT

MODEL

AUC SE

ACC
SEN (%) SPE(%) F1 (%)

PRE (%)

PPV (%) NPV (%)

αCMβE

0.6

2.09 60

79

100

88

100

56

80

αTMβE

0.74

2.07 74

49

100

66

100

67

89

αCMβU

0.61

1.92 61

76

100

87

100

57

81

αTMβU

0.76

1.95 76

45

100

62

100

69

90

αCMβE

0.52

2.67 52

94

83

96

98

51

60

αTMβE

0.6

2.36 60

78

100

87

100

56

78

αCMβU

0.51

1.9

51

96

83

97

98

51

57

αTMβU

0.6

1.69 60

77

100

87

100

56

78

COPD

ASTHMA

The highlighted row indicates the best performer models for COPD and asthma.
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Figure 13. Performance curves for COPD.

Figure 14. Performance curves for asthma.
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Figure 15. ROC curves for COPD.

Figure 16. ROC curves for asthma.
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A default EOI threshold scores (0-1) is set to avoid the overfitting and the best model
ROC curve is shown in the Fig.15 and 16. For COPD, the tangent model (αTM) have better ROC
curve and AUC results. For asthma in the Fig. 16, only the αTMβU performs well.
D.

Population Distributions by Models

The severities based on the generated EOI score are separated as 10, 30 and 50. The model
exploits the observed data set variable dependencies as opposed to the fact of assumptions in the
Figure 17 and 19. The distribution of the asthma subjects and COPD subjects with the healthy
control subjects are shown in the Fig. 18 and 20. The severity 0-4 are separated by the vertical
lines. For COPD according to GOLD [1], the groups are mild, moderate, severe, and very severe.
For asthma according to the GINA guidelines [2], the groups are mild intermittent, mild
persistent, moderate persistent and severe persistent. According to the different severity
separation, the number of subjects is shown in Table VII.
TABLE VII. RESULT OF FREQUENCY DISTRIBUTION
SUBJECT

MODEL

SEV 0

SEV 1

SEV 2

SEV 3

SEV 4

αCMβE

18

31

25

6

5

αTMβE

43

37

7

4

4

αCMβU

20

35

22

3

5

αTMβU

47

25

5

4

4

αCMβE

6

0

0

0

0

αTMβE

6

0

0

0

0

COPD

HEALTHY
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TABLE VII. RESULT OF FREQUENCY DISTRIBUTION (CONTINUED)
αCMβU

6

0

0

0

0

αTMβU

6

0

0

0

0

αCMβE

4

15

25

13

10

αTMβE

15

28

14

6

4

αCMβU

3

15

23

15

11

αTMβU

15

27

14

6

4

αCMβE

5

1

0

0

0

αTMβE

6

0

0

0

0

αCMβU

5

1

0

0

0

αTMβU

6

0

0

0

0

ASTHMA

HEALTHY

The highlighted row indicates the best performer models for COPD and asthma.

Figure 17. COPD Frequency Distribution for four models.
38

Figure 18. EOI plots for COPD Frequency Distribution compared to healthy subjects.

Figure 19. Asthma Frequency Distribution for four models.
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Figure 20. EOI plots for asthma Frequency Distribution compared to healthy subjects.
E.

Comparison of Distributions by Models and K-Means Clustering

In the asthma distribution, the number of subjects in Sev (0- 4) is respectively 15, 28, 14, 6
and 4 by the αTMβE Model. For COPD, the distribution for Sev (0- 4) by αTMβU is 47, 25, 5, 4 and
4. Now, with the help of the K- Means Clustering in Figure 21 and 22, five different clusters are
plotted with principal component 1 in the x-axis and principal component 2 in the y-axis. The
clusters are calculated from the total 10 features (HRi and SpO2i) where i is 0 to 4 and depicts the
severity of the minutes. For Sev (0- 4), COPD 43, 17, 4, 17 and 4 and asthma 17, 10, 28, 4, and 8
are the distributions by the clusters. The confusion matrix for these two results is described in
Table VIII and IX. For Sev (0-4) the exact assignments of groups are 22, 6, 1, 1 and 0 for COPD
and 12, 8, 12, 0, and 3 for asthma respectively.

40

Figure 21. COPD Frequency Distribution by K- Means Clustering.
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TABLE VIII. COPD CONFUSION MATRIX FOR MODEL AND K-MEANS CLUSTERING
αTMβU Model

K- Means

Sev 0

Sev 1

Sev 2

Sev 3

Sev 4

Total

Sev 0

22

10

1

11

3

47

Sev 1

12

6

1

5

1

25

Sev 2

3

1

1

0

0

5

Sev 3

3

0

0

1

0

4

Sev 4

3

0

1

0

0

4

Total

43

17

4

17

4

85

The highlighted cells indicate the correct number of subjects by αTMβU model and K-Means
Clustering for COPD.

Figure 22. Asthma Frequency Distribution by K- Means Clustering.
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TABLE IX.

ASTHMA CONFUSION MATRIX FOR MODEL AND K-MEANS CLUSTERING

αTMβE Model

K- Means

Sev 0

Sev 1

Sev 2

Sev 3

Sev 4

Total

Sev 0

12

0

3

0

0

15

Sev 1

5

8

11

3

1

28

Sev 2

0

1

12

0

1

14

Sev 3

0

1

2

0

3

6

Sev 4

0

0

0

1

3

4

Total

17

10

28

4

8

67

The highlighted cells indicate the matched number of subjects by αTMβE model and K-Means
Clustering for asthma.

43

Figure 23. COPD Frequency Distribution for αTMβU model and K-means clustering.

Figure 24. Asthma Frequency Distribution for αTMβE model and K-means clustering.
Distributions by Models and K-Means Clustering in the severity 0 to 4 are plotted in
comparative figures, for COPD in the Figure 23 and for asthma in the Figure 24. For COPD Sev3 varies a lot while Sev-1 and Sev-2 stands the anomalies in case of asthma.
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V.

CONCLUSION

A. Summary of Findings
Asthma and chronic obstructive pulmonary disease are prevalent in older adults and
smokers. Therefore, a severity classifier implementation will help to check the level of sickness
for the patient. In this study, a simple approach is proposed based on the duration of the time
passed for each vital sign. Accordingly, the proposed system of calculating severity as an Event of
Interest (EOI) is consisted of a scaled value to inform the patient about the severity based on the
score generated by using the system. The novel contribution of the proposed is both the feature
and the algorithm, which are flexible, reliable, and simple.
We designed and evaluated several models to develop a clinical decision support system
to aid in the diagnosis of severities in patients with asthma and COPD. Because there are many
asthmatics and COPD patients and huge economic costs associated with the diseases, simple but
low levels of efficacy can contribute to improving patient health via self-management. The EOI
value depends upon both of SpO2 and heart rate, so the fluctuations of heart rate or SpO2 because
of reasons other than the severity of the diseases will not cause a rise of false positives. Moreover,
the number of sensors used for the assessment is only the pulse oximeter which is easy to deploy
and manage.
In this work, we show that chronic obstructive pulmonary disease and asthma can be
monitored with only heart rate and SpO2, both of which can be obtained from a single pulse
oximetry sensor. Additionally, the proposed algorithm is simple and easy to implement that can
allow patient self-management of asthma or COPD condition. This can improve patient health
status, reduce the burden on the hospital and improve the overall health of the community of SCC.
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B. Future Directions
The number of healthy subjects used in this study was low compared with COPD and
asthma patients and there is probability of irregular representations which is not prevalent here for
the classification. The collected datasets are from ICU patients, so the algorithm needs revaluation
for home management with data collected in home settings. The results are not directly confirmed
because the “true” values of estimated parameters are not included in the databases. Due to the
absence of data labeling, applicable unsupervised learning and pattern recognition techniques are
suitable for future exploration, however required assessment with ground truth. The proposed
algorithm uses retrospective data from the publicly available databases and contribute to the
advancement in the home management system for the patient well-being. In the absence of the
ground truth value, in another work, we followed established clinical criteria and confirmed with
k means clustering [28].
In this work, the algorithm is developed by using ICU patients’ information, but this
algorithm can be applicable for subjects at home environment in real life settings where they can
perform routine daily tasks freely. In future implementation, further evaluations in home settings
are necessary, as well as implementation of the algorithm in wearables to conduct clinical studies.
The increase in number of healthy subjects will be helpful in future analysis. During data
processing the maximum length of missing data are not considered here to make constraints for
linear assumptions. Incorporation of the length could be considered in further future studies.
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Appendix
MATLAB Code
A.

Functions

function [EOI_D,N] = Fnctn(HR, SP, d)
% This function Fnctn for function graph will process with mean imputation
and EOI and Severity of it.
%Declaration
hrl
hru
spl
spu

=
=
=
=

40; %lower limit
200; %uppur limit
20; %lower limit
100; %uppur limit

% HR labels line level 1 2 and 3
hr1 = 90; %lower limit
hr2 = 100; %Mid-Level
hr3 = 110; %Mid 2 limit
hr4 = 120; %uppur limit
%SpO2
sp1 =
sp2 =
sp3 =
sp4 =

labels line level 1 2 and 3
92; %lower limit
90; %Mid-Level
85; %upur limit
80; %upper limit

% Data Processing
kx = HR;
kx(kx<=hrl) = nan;
kx(kx>=hru) = nan;
x = fillmissing(kx,'linear');
A = 60/30; %1min/30s = samples per minute
B = reshape(x(1:numel(x)-mod(numel(x),2)),[A,(numel(x)-mod(numel(x),2))/A]);
xx=mean(B)';
if mod(numel(x),2)==1
xx = [xx;x(numel(x))];
end
ky= SP;
ky(ky<spl) = nan;
ky(ky>spu) = nan;
y = fillmissing(ky,'linear');
BB = reshape(y(1:numel(y)-mod(numel(y),2)),[A,(numel(y)-mod(numel(y),2))/A]);
yy=mean(BB)';
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if mod(numel(y),2)==1
yy = [yy;y(numel(y))];
end
xx(xx<hrl) = hrl;
xx(xx>hru) = hru;
yy(yy<spl) = spl;
yy(yy>spu) = spu;
% severity_HR
Level_HR(xx<=hr1
Level_HR(xx<=hr2
Level_HR(xx<=hr3
Level_HR(xx<=hr4
Level_HR(xx<=hru

&
&
&
&
&

xx>hrl)
xx>hr1)
xx>hr2)
xx>hr3)
xx>hr4)

=
=
=
=
=

0;
1;
2;
3;
4;

%severity SpO2
Level_SP(yy<=sp4) = 4;
Level_SP(yy<=sp3 & yy>sp4) = 3;
Level_SP(yy<=sp2 & yy>sp3) = 2;
Level_SP(yy<=sp1 & yy>sp2) = 1;
Level_SP(yy>sp1) = 0;
%Data for severity
C_HR = categorical(Level_HR,[0 1 2 3 4],{'Normal','Mild','Moderate',
'Severe', 'Very Severe'});
[HR_Total_Minutes] = histcounts(C_HR);%HR Histcounts
C_SP = categorical(Level_SP,[0 1 2 3 4],{'Normal','Mild','Moderate',
'Severe', 'Very Severe'});
[SP_Total_Minutes] = histcounts(C_SP);% SpO2 data for severity
HRTM = HR_Total_Minutes;
SPTM = SP_Total_Minutes;
r= HRTM*100/sum(HRTM);%Normalize (taking percentage values of HR)
p= SPTM*100/sum(SPTM); %Normalize (taking percentage values of SpO2)
x2 = [1 22.5 45 67.5 89];
yy7 = tand(x2);
y7 = 100 * yy7/sum (yy7);
round (y7,2)
if d==1
beta = [0.4 0.6]; % For COPD
[EOI_Total] = EOItan(r,p,beta,y7);
Normalised_EOI = 100*(EOI_Total - 2.8551)/4.3833e+03;
EOI_D = Normalised_EOI;
else
beta = [0.5 0.5]; % For Asthma
[EOI_Total] = EOItan(r,p,beta,y7);
Normalised_EOI = 100*(EOI_Total - 2.8551)/3.2781e+03;
EOI_D = Normalised_EOI;
end
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% Severity
edges = [0 1.5 9.5 29.5 49.5 100];
N = histcounts(EOI_D,edges);
end
function [EOI_Total] = EOItan(r,p,beta,y7)
% EOI Model 7
b_HR = beta (1);
b_SP = beta (2);
alpha = y7;
HR_individual = (alpha.*r);
EOI_HR= sum (HR_individual,2);
SP_idividual = (alpha.*p);
EOI_SP = sum (SP_idividual,2);
%EOI_HR_SP = (b_HR * EOI_HR + b_SP * EOI_SP);
%EOI_Total = [EOI_HR_SP EOI_HR EOI_SP];
EOI_Total = (b_HR * EOI_HR + b_SP * EOI_SP);
end

B.

Data Processing

(i)

Data Processing of Sample Healthy Subjects

% Healthy 7-16
f = 1;
data_a = 0;
data_b = 0;
SpO2_Row = 3;
HR_row = 4;
% reading xls file for Healthy 16
data = xlsread('10_1_Healthy16.xlsx'); % reading xls file
[r,p] = fileno(data, data_a, data_b, f, SpO2_Row, HR_row);
r16 = r;
p16 = p;
% reading xls file for Healthy 15
data = xlsread('9_1_Healthy15.xlsx'); % reading xls file
[r,p] = fileno(data, data_a, data_b, f, SpO2_Row, HR_row);
r15 = r;
p15 = p;
% reading xls file for Healthy 14
data = xlsread('8_1_Healthy14.xlsx'); % reading xls file
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[r,p] = fileno(data, data_a, data_b, f, SpO2_Row, HR_row);
r14 = r;
p14 = p;
% reading xls file for Healthy 13
data = xlsread('7_1_Healthy13.xlsx'); % reading xls file
data_a = 0; % reading xls file;
data_b = 0; % reading xls file;
[r,p] = fileno(data, data_a, data_b, f, SpO2_Row, HR_row);
r13 = r;
p13 = p;
% reading xls file for Healthy 12
data = xlsread('6_1_Healthy12.xlsx'); % reading xls file
data_a = 0; % reading xls file;
data_b = 0; % reading xls file;
[r,p] = fileno(data, data_a, data_b, f, SpO2_Row, HR_row);
r12 = r;
p12 = p;
% reading xls file for Healthy 11
data = xlsread('5_1_Healthy11.xlsx'); % reading xls file
data_a = 0; % reading xls file;
data_b = 0; % reading xls file;
[r,p] = fileno(data, data_a, data_b, f, SpO2_Row, HR_row);
r11 = r;
p11 = p;
% reading xls file for Healthy 10
data = xlsread('4_1_Healthy10.xlsx'); % reading xls file
data_a = 0; % reading xls file;
data_b = 0; % reading xls file;
[r,p] = fileno(data, data_a, data_b, f, SpO2_Row, HR_row);
r10 = r;
p10 = p;
% reading xls file for Healthy 9
f = 1;
data = xlsread('3_1_Healthy9.xlsx'); % reading xls file
data_a = 0; % reading xls file;
data_b = 0; % reading xls file;
[r,p] = fileno(data, data_a, data_b, f, SpO2_Row, HR_row);
r9 = r;
p9 = p;
% reading xls file for Healthy 8
f = 1;
data = xlsread('2_1_Healthy8.xlsx'); % reading xls file
data_a = 0; % reading xls file;
data_b = 0; % reading xls file;
[r,p] = fileno(data, data_a, data_b, f, SpO2_Row, HR_row);
r8 = r;
p8 = p;
% reading xls file for Healthy 7
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SpO2_Row = 3;
HR_row = 2;
data = xlsread('1_1_Healthy7.xlsx'); % reading xls file
data_a = 0; % reading xls file;
data_b = 0; % reading xls file;
[r,p] = fileno(data, data_a, data_b, f, SpO2_Row, HR_row);
r7 = r;
p7 = p;
load('matlab6old.mat');
percent_Values_HR_Healthy =
[percentValuesHRHealthy;r7;r8;r9;r10;r11;r12;r13;r14;r15;r16];
percent_Values_SP_Healthy =
[percentValuesSPHealthy;p7;p8;p9;p10;p11;p12;p13;p14;p15;p16];
load('matlab6.mat');

(ii)

Number of Files and Samples Processing

function [r,p] = fileno(data, data_a, data_b, f, SpO2_Row, HR_row)
% This function fileno for function graph will process with mean imputation
from the database used for it.
Plot = 0;
if f == 1
HR=data(:,HR_row); % reading its first column
SP=data(:,SpO2_Row); % reading its column
[HR_Total_Minutes,SP_Total_Minutes] = fg(HR, SP, Plot);
%set(gcf, 'units','normalized','outerposition',[0 0 1 1]);
%saveas(Plot,'SubjectCOPD.jpg');
HRTM = HR_Total_Minutes;
SPTM = SP_Total_Minutes;
r= HRTM*100/sum(HRTM);%Normalize (taking percentage values of HR)
p= SPTM*100/sum(SPTM); %Normalize (taking percentage values of SpO2)
end
if f == 2
HR=data(:,HR_row); % reading its first column
SP=data(:,SpO2_Row); % reading its column
[HR_Total_Minutes,SP_Total_Minutes] = fg(HR, SP, Plot);
%set(gcf, 'units','normalized','outerposition',[0 0 1 1]);
%saveas(Plot,'SubjectCOPD.jpg');
HR_1 = HR_Total_Minutes;
SP_1 = SP_Total_Minutes;
HR=data_a(:,HR_row); % reading its first column
SP=data_a(:,SpO2_Row); % reading its column
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[HR_Total_Minutes,SP_Total_Minutes] = fg(HR, SP, Plot);
%set(gcf, 'units','normalized','outerposition',[0 0 1 1]);
%saveas(Plot,'SubjectCOPDa.jpg');
HR_2 = HR_Total_Minutes;
SP_2 = SP_Total_Minutes;
HRTM = HR_1 + HR_2;
SPTM = SP_1 + SP_2;
r= HRTM*100/sum(HRTM);%Normalize (taking percentage values of HR)
p= SPTM*100/sum(SPTM); %Normalize (taking percentage values of SpO2)
end
if f == 3
HR=data(:,HR_row); % reading its first column
SP=data(:,SpO2_Row); % reading its column
[HR_Total_Minutes,SP_Total_Minutes] = fg(HR, SP, Plot);
%set(gcf, 'units','normalized','outerposition',[0 0 1 1]);
%saveas(Plot,'SubjectCOPD.jpg');
HR_1 = HR_Total_Minutes;
SP_1 = SP_Total_Minutes;
HR=data_a(:,HR_row); % reading its first column
SP=data_a(:,SpO2_Row); % reading its column
[HR_Total_Minutes,SP_Total_Minutes] = fg(HR, SP, Plot);
%set(gcf, 'units','normalized','outerposition',[0 0 1 1]);
%saveas(Plot,'SubjectCOPDa.jpg');
HR_2 = HR_Total_Minutes;
SP_2 = SP_Total_Minutes;
HR=data_b(:,HR_row); % reading its first column
SP=data_b(:,SpO2_Row); % reading its column
[HR_Total_Minutes,SP_Total_Minutes] = fg(HR, SP, Plot);
%set(gcf, 'units','normalized','outerposition',[0 0 1 1]);
%saveas(Plot,'SubjectCOPDb.jpg');
HR_3 = HR_Total_Minutes;
SP_3 = SP_Total_Minutes;
HRTM = HR_1 + HR_2 + HR_3;
SPTM = SP_1 + SP_2 + SP_3;
r= HRTM*100/sum(HRTM);%Normalize (taking percentage values of HR)
p= SPTM*100/sum(SPTM); %Normalize (taking percentage values of SpO2)
end
end
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(iii)

Raw Data Processing

function [HR_Total_Minutes,SP_Total_Minutes] = fg(HR, SP, Plot)
% This function fg for function graph will process with mean imputation from
the database used for it.
%Declaration
hrl
hru
spl
spu

=
=
=
=

40; %lower limit
200; %uppur limit
20; %lower limit
100; %uppur limit

% HR labels line level 1 2 and 3
hr1 = 90; %lower limit
hr2 = 100; %Mid-Level
hr3 = 110; %Mid 2 limit
hr4 = 120; %uppur limit
%SpO2
sp1 =
sp2 =
sp3 =
sp4 =

labels line level 1 2 and 3
92; %lower limit
90; %Mid-Level
85; %upur limit
80; %upper limit

% Data Processing
kx = HR;
kx(kx<=hrl) = nan;
kx(kx>=hru) = nan;
x = fillmissing(kx,'linear');
A = 60/30; %1min/30s = samples per minute
B = reshape(x(1:numel(x)-mod(numel(x),2)),[A,(numel(x)-mod(numel(x),2))/A]);
xx=mean(B)';
if mod(numel(x),2)==1
xx = [xx;x(numel(x))];
end
ky= SP;
ky(ky<spl) = nan;
ky(ky>spu) = nan;
y = fillmissing(ky,'linear');
BB = reshape(y(1:numel(y)-mod(numel(y),2)),[A,(numel(y)-mod(numel(y),2))/A]);
yy=mean(BB)';
if mod(numel(y),2)==1
yy = [yy;y(numel(y))];
end
xx(xx<hrl) = hrl;
xx(xx>hru) = hru;
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yy(yy<spl) = spl;
yy(yy>spu) = spu;
% severity_HR
Level_HR(xx<=hr1
Level_HR(xx<=hr2
Level_HR(xx<=hr3
Level_HR(xx<=hr4
Level_HR(xx<=hru

&
&
&
&
&

xx>hrl)
xx>hr1)
xx>hr2)
xx>hr3)
xx>hr4)

=
=
=
=
=

0;
1;
2;
3;
4;

%severity SpO2
Level_SP(yy<=sp4) = 4;
Level_SP(yy<=sp3 & yy>sp4) = 3;
Level_SP(yy<=sp2 & yy>sp3) = 2;
Level_SP(yy<=sp1 & yy>sp2) = 1;
Level_SP(yy>sp1) = 0;
%Data for severity
C_HR = categorical(Level_HR,[0 1 2 3 4],{'Normal','Mild','Moderate',
'Severe', 'Very Severe'});
[HR_Total_Minutes] = histcounts(C_HR);%HR Histcounts
C_SP = categorical(Level_SP,[0 1 2 3 4],{'Normal','Mild','Moderate',
'Severe', 'Very Severe'});
[SP_Total_Minutes] = histcounts(C_SP);% SpO2 data for severity
if Plot == 1
Plot = figure;
subplot (2,4,1);
plot (HR);
%hline = refline([0 hr]); hline.Color = 'r';
title('Heart rate')
%hline = refline([0 hrl]); hline.Color = 'b'; hline = refline([0 hru]);
hline.Color = 'g';
xlabel('Minutes', 'FontSize',10,'FontWeight','bold'); ylabel('BPM'); grid on;
%legend('Original Data',['Ref line =' num2str(hr)],['Lower limit = '
num2str(hrl)],['Uppur limit = ' num2str(hru)]);
subplot (2,4,2);
plot (xx);
%hline = refline([0 hr1]); hline.Color = 'g';
%hline = refline([0 hr2]); hline.Color = 'c';
%hline = refline([0 hr3]); hline.Color = 'b';
%hline = refline([0 hr4]); hline.Color = 'r';
title('HR processed')
xlabel('Minutes', 'FontSize',10,'FontWeight','bold'); ylabel('BPM'); grid on;
%legend('Original Data', 'Normal','Mild', 'Moderate', 'Severe');
subplot (2,4,5);
plot (SP);
%hline = refline([0 sp]); hline.Color = 'r';
title('SpO2')
%hline = refline([0 spl]); hline.Color = 'b'; hline = refline([0 spu]);
hline.Color = 'g';
xlabel('Minutes', 'FontSize',10,'FontWeight','bold'); ylabel('%'); grid on;
%legend('Original Data','Ref line', 'Lower limit', 'Uppur limit');
subplot (2,4,6);
plot (yy);
%hline = refline([0 sp4]); hline.Color = 'g';
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%hline = refline([0 sp3]); hline.Color = 'c';
%hline = refline([0 sp2]); hline.Color = 'b';
%hline = refline([0 sp1]); hline.Color = 'r';
title('SpO2 processed')
xlabel('Minutes', 'FontSize',10,'FontWeight','bold'); ylabel('%'); grid on;
%legend('Original Data', 'Normal','Mild', 'Moderate', 'Severe');
subplot (2,4,3);
histogram(C_HR,'BarWidth',0.5);
title('HR Bar Graph')
xlabel('Severity Level HR', 'FontSize',10,'FontWeight','bold'); ylabel('Total
Minutes'); grid on;
subplot (2,4,4);
pie (C_HR); title('Severity Pie Level HR');
subplot (2,4,7);
histogram(C_SP,'BarWidth',0.5);
title('SpO2 Bar Graph')
xlabel('Severity Level SpO2', 'FontSize',10,'FontWeight','bold');
ylabel('Total Minutes'); grid on;
subplot (2,4,8);
pie (C_SP); title('Severity Pie Level SpO2');
end
end

C.

Plotting

(i)

Figure 4

x = [0.01 0.1 1 10 100];
x1 = [2 3 4 5 6];
x2 = [1 22.5 45 67.5 89];
y6 = 100 * x/sum (x);
yy3 = sqrt (x);
y3 = 100 * yy3/sum (yy3);
round (y3,2)

yy1 = x1.^3;
y1 = 100 * yy1/sum (yy1);
yy4 = 4.^x1;
y4 = round (100 * yy4/sum (yy4),2);

yy5 = x1.^10;
y5 = 100 * yy5/sum (yy5);
round (y5,2)
yy2 = exp (x1);
y2 = 100 * yy2/sum (yy2);
y2 = round (y2,2)
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yy7 = tand(x2);
y7 = 100 * yy7/sum (yy7);
round (y7,2)
figure
plot (y1, '-bo','DisplayName','\alpha_C_M','LineWidth',5)
legend('show')
hold on
plot (y2,'-go','DisplayName','\alpha_E_M','LineWidth',5)
legend ('show');
plot (y3,'k--o','DisplayName','\alpha_S_M','LineWidth',5)
legend ('show');
plot (y4,'-ms','DisplayName','\alpha_F_M','LineWidth',5)
legend ('show');
plot (y5,'--bs','DisplayName','\alpha_P_M','LineWidth',5)
legend ('show');
plot (y6,'-cd','DisplayName','\alpha_I_M','LineWidth',5)
legend ('show');
plot (y7,'-r*','DisplayName','\alpha_T_M','LineWidth',5)
legend ('show');
xlabel ('Severity')
ylabel ('\alpha')
set(gca,'YTick',0:10:100);
cstr = {'0-Normal','1-Mild','2-Moderate', '3-Severe', '4-Very Severe'};
set(gca, 'XTickLabel',cstr, 'XTick',1:numel(cstr), 'fontsize',30);
set(gca,'fontsize',37);

(ii)

Figure 5

%%%%%%%%%%%%%% beta lines polynomial %%%%%%%%%%%%%
beta_all = [0.5 0.5;
0.4 0.6;
0.2 0.8];
load matlab6; %%%%%%%%%%%%%% All outputs saved here %%%%%%%%%%%%%
A = ["Normal","Very Severe"];
%r = [percent_Values_HR_COPD; percent_Values_HR_Asthma;
percentValuesHRHealthy];
%p = [percent_Values_SP_COPD; percent_Values_SP_Asthma;
percentValuesSPHealthy];
%r = [percent_Values_HR_Asthma; percentValuesHRHealthy];
%p = [percent_Values_SP_Asthma; percentValuesSPHealthy];

62

r = [percent_Values_HR_COPD; percent_Values_HR_Healthy];
p = [percent_Values_SP_COPD; percent_Values_SP_Healthy];
h (1) = figure;
pt = ones(3,1);
Color = {'[1 0.4 0.6]','[0.5 0.5 0.5]','c'}; % Cell array of
colros.pink,grey,cyan
for u = 5
subplot (2,2,2)
for b = 1:3
beta = beta_all (b,:);
Model_Results = models (beta);
for j = 1:2
%k = j + 2*(j-1);
x = Model_Results (:,j);
plfit = polyfit(x,p(:,u),1);
x1 = linspace(0,100);
y1 = polyval(plfit,x1);
plot(x1,y1,'lineWidth',1.5, 'LineStyle', '--','color',Color{b})
hold on
end
set(gca,'fontsize',14);
xlim([0 100])
set(gca,'XTick',0:10:100);
ylim ([0 100])
set(gca,'YTick',0:10:100);
%title(['Severity ', num2str(u)], 'FontSize',10)
%xlabel('EOI', 'FontSize',10,'FontWeight','bold');
%ylabel('SpO2: % of minutes', 'FontSize',10,'FontWeight','bold');
end
end
for s = 5
subplot (2,2,2)
for b = 1:3
beta = beta_all (b,:);
Model_Results = models (beta);
for j = 1:2
%k = j + 2*(j-1);
x = Model_Results (:,j);
plfit = polyfit(x,r(:,s),1);
x1 = linspace(0,100);
y1 = polyval(plfit,x1);
pt(b) = plot(x1,y1, 'lineWidth',1.5,'color',Color{b});
hold on
end
set(gca,'fontsize',14);
xlim([0 100])
ylim ([0 100])
title({'Severity- 4';A(2)},'FontSize',25);
%xlabel('EOI', 'FontSize',10,'FontWeight','bold');
ylabel('Percentage of Minutes', 'FontSize',20,'FontWeight','bold');
end
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if s==5
lgd = legend(pt,
{'\beta_E','\beta_U','\beta_O'},'Location','best','FontSize',20,'AutoUpdate',
'off');
title(lgd,'HR')
end
end
for u = 1
subplot (2,2,1)
for b = 1:3
beta = beta_all (b,:);
Model_Results = models (beta);
for j = 1:2
%k = j + 2*(j-1);
x = Model_Results (:,j);
plfit = polyfit(x,p(:,u),1);
x1 = linspace(0,100);
y1 = polyval(plfit,x1);
plot(x1,y1,'lineWidth',1.5, 'LineStyle', '--','color',Color{b})
hold on
end
set(gca,'fontsize',14);
xlim([0 100])
set(gca,'XTick',0:10:100);
ylim ([0 100])
set(gca,'YTick',0:10:100);
%title(['Severity ', num2str(u)], 'FontSize',10)
%xlabel('EOI', 'FontSize',10,'FontWeight','bold');
%ylabel('SpO2: % of minutes', 'FontSize',10,'FontWeight','bold');
end
end
for s = 1
subplot (2,2,1)
for b = 1:3
beta = beta_all (b,:);
Model_Results = models (beta);
for j = 1:2
%k = j + 2*(j-1);
x = Model_Results (:,j);
plfit = polyfit(x,r(:,s),1);
x1 = linspace(0,100);
y1 = polyval(plfit,x1);
pt(b) = plot(x1,y1, 'lineWidth',1.5,'color',Color{b});
hold on
end
set(gca,'fontsize',14);
xlim([0 100])
ylim ([0 100])
title({['Severity- ',num2str(s-1)];A(s)},'FontSize',25);
%xlabel('EOI', 'FontSize',10,'FontWeight','bold');
ylabel('Percentage of Minutes', 'FontSize',20,'FontWeight','bold');
end
end
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r = [percent_Values_HR_Asthma; percent_Values_HR_Healthy];
p = [percent_Values_SP_Asthma; percent_Values_SP_Healthy];
for u = 1
subplot (2,2,u+2)
for b = 1:3
beta = beta_all (b,:);
Model_Results = Asthmamodels (beta);
for j = 1:2
%k = j + 2*(j-1);
x = Model_Results (:,j);
plfit = polyfit(x,p(:,u),1);
x1 = linspace(0,100);
y1 = polyval(plfit,x1);
plot(x1,y1,'lineWidth',1.5,'LineStyle', '-.','color',Color{b})
hold on
end
end
end
hold on
for s = 5
subplot (2,2,4)
for b = 1:3
beta = beta_all (b,:);
Model_Results = Asthmamodels (beta);
for j = 1:2
%k = j + 2*(j-1);
x = Model_Results (:,j);
plfit = polyfit(x,r(:,s),1);
x1 = linspace(0,100);
y1 = polyval(plfit,x1);
pt(b) = plot(x1,y1, 'lineWidth',1.5,'color',Color{b});
hold on
end
set(gca,'fontsize',14);
set(gca,'XTick',0:10:100);
set(gca,'YTick',0:10:100);
xlim([0 100])
ylim ([0 100])
%title({['Severity- ',num2str(s)];A(s+1)},'FontSize',15);
xlabel('EOI', 'FontSize',20,'FontWeight','bold');
ylabel('Percentage of Minutes', 'FontSize',20,'FontWeight','bold');
end
end
for u = 5
subplot (2,2,4)
for b = 1:3
beta = beta_all (b,:);
Model_Results = Asthmamodels (beta);
for j = 1:2
%k = j + 2*(j-1);
x = Model_Results (:,j);
plfit = polyfit(x,p(:,u),1);
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x1 = linspace(0,100);
y1 = polyval(plfit,x1);
pt(b) = plot(x1,y1,'lineWidth',1.5,'LineStyle', '-.','color',Color{b});
hold on
end
end
if u==5
lgdd = legend(pt,
{'\beta_E','\beta_U','\beta_O'},'Location','best','FontSize',20,'AutoUpdate',
'off');
title(lgdd,'SpO_2')
end
end
hold on
for s = 1
subplot (2,2,3)
for b = 1:3
beta = beta_all (b,:);
Model_Results = Asthmamodels (beta);
for j = 1:2
%k = j + 2*(j-1);
x = Model_Results (:,j);
plfit = polyfit(x,r(:,s),1);
x1 = linspace(0,100);
y1 = polyval(plfit,x1);
plot(x1,y1, 'lineWidth',1.5,'color',Color{b});
hold on
end
set(gca,'fontsize',14);
set(gca,'XTick',0:10:100);
set(gca,'YTick',0:10:100);
xlim([0 100])
ylim ([0 100])
%title({['Severity- ',num2str(s)];A(s+1)},'FontSize',15);
xlabel('EOI', 'FontSize',20,'FontWeight','bold');
ylabel('Percentage of Minutes', 'FontSize',20,'FontWeight','bold');
end
end

(iii)

Figure 6

load matlab6;
r = [percent_Values_HR_COPD; percent_Values_HR_Asthma;
percent_Values_HR_Healthy];
p = [percent_Values_SP_COPD; percent_Values_SP_Asthma;
percent_Values_SP_Healthy];
combined = [r p];
set(0,'defaultTextFontSize',35);
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[coeff,score,latent,tsquared,explained,mu] = pca(combined);
figure
plot (explained,'b-o', 'lineWidth',3)
hold on
plot (cumsum(explained),'r-d', 'lineWidth',3)
xlabel ('Principal Components'); ylabel ('PVE (%)'); ylim ([0 101]); xlim ([1
10]);
legend({'Proportion of Variance Explained','Cumulative Proportion of Variance
Explained'})
set(gca,'fontsize',30);

(iv)

Figure 7

% reading xls file for COPD 1
data1=xlsread('p011785-COPD1.xlsx'); % reading xls file
HR=data1(:,2); % reading its first column
SP=data1(:,8); % reading its eightgh column
[HR_Total_Minutes,SP_Total_Minutes] = fg(HR, SP, 0);
HR1_1 = HR_Total_Minutes;
SP1_1 = SP_Total_Minutes;
data1a=xlsread('p011785-COPD1a.xlsx'); % reading xls file
HR=data1a(:,2); % reading its first column
SP=data1a(:,8); % reading its eightgh column
[HR_Total_Minutes,SP_Total_Minutes] = fg(HR, SP, 0);
HR1_2 = HR_Total_Minutes;
SP1_2 = SP_Total_Minutes;
HR1 = HR1_1 + HR1_2;
SP1 = SP1_1 + SP1_2;
r1= HR1*100/sum(HR1);%Normalize (taking percetage values of HR)
p1= SP1*100/sum(SP1); %Normalize (taking percetage values of SpO2)
% reading xls file for Asthma 2
f = 1;
SpO2_Row = 5;
HR_row = 2;
data = xlsread('40355_2.xlsx'); % reading xls file
data_a = 0; % reading xls file
data_b = 0; % reading xls file;
[r,p] = fileno(data, data_a, data_b, f, SpO2_Row, HR_row);
r2 = r;
p2 = p;
% reading xls file for Healthy 5
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f = 1;
SpO2_Row = 5;
HR_row = 2;
data = xlsread('capslpdbn5.xlsx'); % reading xls file
data_a = 0; % reading xls file
data_b = 0; % reading xls file;
[r,p] = fileno(data, data_a, data_b, f, SpO2_Row, HR_row);
r5 = r;
p5 = p;
labels = {'NOR:';'MIL:';'MOD:';'SEV:';'VES:'};
colormap([1 1 1;
%// green white
1 1 0; %// grey yellow
0.9100 0.4100 0.1700;
%// blue orange
0.5430 0 0;
%// magenta dark red
0 0 0]) %// red black
hh = r1;
z =(hh == 0);
hh = hh + z*realmin;
pp = p1;
z =(pp == 0);
pp = pp + z*realmin;
subplot (3,2,1)
phr = pie (hh);
title ({'\fontsize{15}Heart Rate'; '\fontsize{14}\color{blue}COPD'})
hText = findobj(phr,'Type','text'); % text object handles
percentValues = get(hText,'String'); % percent values
combinedtxt = strcat(labels,percentValues); % strings and percent values
hText(1).String
hText(2).String
hText(3).String
hText(4).String
hText(5).String

=
=
=
=
=

combinedtxt(1);
combinedtxt(2);
combinedtxt(3);
combinedtxt(4);
combinedtxt(5);

for w = 2:2:10
t = phr(w);
t.FontSize = 10;
end
subplot (3,2,2)
psp = pie (pp);
title ({'\fontsize{15}SPO_2'; '\fontsize{14}\color{blue}COPD'})
hText = findobj(psp,'Type','text'); % text object handles
percentValues = get(hText,'String'); % percent values
combinedtxt = strcat(labels,percentValues); % strings and percent values
hText(1).String = combinedtxt(1);
hText(2).String = combinedtxt(2);
hText(3).String = combinedtxt(3);

68

hText(4).String = combinedtxt(4);
hText(5).String = combinedtxt(5);
for w = 2:2:10
t = psp(w);
t.FontSize = 10;
end
hh = r2;
z =(hh == 0);
hh = hh + z*realmin;
pp = p2;
z =(pp == 0);
pp = pp + z*realmin;
subplot (3,2,3)
phr = pie (hh);
title ('\fontsize{14}\color{magenta}Asthma')
hText = findobj(phr,'Type','text'); % text object handles
percentValues = get(hText,'String'); % percent values
combinedtxt = strcat(labels,percentValues); % strings and percent values
hText(1).String
hText(2).String
hText(3).String
hText(4).String
hText(5).String

=
=
=
=
=

combinedtxt(1);
combinedtxt(2);
combinedtxt(3);
combinedtxt(4);
combinedtxt(5);

for w = 2:2:10
t = phr(w);
t.FontSize = 10;
end
subplot (3,2,4)
psp = pie (pp);
title ('\fontsize{14}\color{magenta}Asthma')
hText = findobj(psp,'Type','text'); % text object handles
percentValues = get(hText,'String'); % percent values
combinedtxt = strcat(labels,percentValues); % strings and percent values
hText(1).String
hText(2).String
hText(3).String
hText(4).String
hText(5).String

=
=
=
=
=

combinedtxt(1);
combinedtxt(2);
combinedtxt(3);
combinedtxt(4);
combinedtxt(5);

for w = 2:2:10
t = psp(w);
t.FontSize = 10;
end
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hh = r5;
z =(hh == 0);
hh = hh + z*realmin;
pp = p5;
z =(pp == 0);
pp = pp + z*realmin;
subplot (3,2,5)
phr = pie (hh);
title ('\fontsize{14}\color{green}Healthy')
hText = findobj(phr,'Type','text'); % text object handles
percentValues = get(hText,'String'); % percent values
combinedtxt = strcat(labels,percentValues); % strings and percent values
hText(1).String
hText(2).String
hText(3).String
hText(4).String
hText(5).String

=
=
=
=
=

combinedtxt(1);
combinedtxt(2);
combinedtxt(3);
combinedtxt(4);
combinedtxt(5);

for w = 2:2:10
t = phr(w);
t.FontSize = 10;
end
subplot (3,2,6)
psp = pie (pp);
title ('\fontsize{14}\color{green}Healthy')
hText = findobj(psp,'Type','text'); % text object handles
percentValues = get(hText,'String'); % percent values
combinedtxt = strcat(labels,percentValues); % strings and percent values
hText(1).String
hText(2).String
hText(3).String
hText(4).String
hText(5).String

=
=
=
=
=

combinedtxt(1);
combinedtxt(2);
combinedtxt(3);
combinedtxt(4);
combinedtxt(5);

for w = 2:2:10
t = psp(w);
t.FontSize = 10;
end

D.

Statistical Analysis

(i)

Figure 8 and 9

load matlab6;
cstr = {'NOR','MIL','MOD', 'SEV', 'VES'};
%Heart Rate Plot

70

x1 = percent_Values_HR_COPD;
x2 = percent_Values_HR_Asthma;
%x3 = percentValuesHRHealthy;
x3 = percent_Values_HR_Healthy;
pos1 = (5:5:25)';
pos2 = (6:5:26)';
pos3 = (7:5:27)';
g =[0 1 2 3 4];
whiskerno = 3;
figure
subplot (1,2,1)
h1 = boxplot(x1, g, 'Colors','b', 'Positions',pos1,
'Width',0.8,'whisker',whiskerno);
set(h1,'LineWidth',5);
hold on
h3 = boxplot(x3, g, 'Colors','g', 'Positions',pos3,
'Width',0.8,'whisker',whiskerno);
set(h3,'LineStyle','-','LineWidth',5);
h2 = boxplot(x2, g, 'Colors','m', 'Positions',pos2,
'Width',0.8,'whisker',whiskerno);
set(h2,'LineWidth',5);
hold off
set(gca,'fontsize',30)
title ('(a)', 'FontSize',30)
xlabel('Severity Level for Heart Rate', 'FontSize',30,'FontWeight','bold');
ylabel('Percentage of Minutes', 'FontSize',30,'FontWeight','bold');
set(gca, 'XTickLabel',cstr);
%legend([h1(5,1),h2(5,1),h3(5,1)],
{'COPD','Asthma','Healthy'},'FontSize',30,'AutoUpdate','off')
color = repelem(['m', 'g', 'b'], 5);
h = findobj(gca,'Tag','Box');
for j=1:length(h)
patch(get(h(j),'XData'),get(h(j),'YData'),color(j),'FaceAlpha',.5);
end
% legend([h1(5,1),h2(5,1),h3(5,1)],
{'COPD','Asthma','Healthy'},'FontSize',30,'AutoUpdate','off')
set(gca,'YTick',0:10:100);
%SpO2 Plot
y1 = percent_Values_SP_COPD;
y2 = percent_Values_SP_Asthma;
%y3 = percentValuesSPHealthy;
y3 = percent_Values_SP_Healthy;
pos1 = (5:5:25)';
pos2 = (6:5:26)';
pos3 = (7:5:27)';
g =[0 1 2 3 4];
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whiskerno = 5;
%figure
subplot (1,2,2)
h1 = boxplot(y1, g, 'Colors','b', 'Positions',pos1,
'Width',0.8,'whisker',whiskerno);
set(h1,'LineWidth',5);
hold on
h3 = boxplot(y3, g, 'Colors','g', 'Positions',pos3,
'Width',0.8,'whisker',whiskerno);
set(h3,'LineWidth',5);
h2 = boxplot(y2, g, 'Colors','m', 'Positions',pos2,
'Width',0.8,'whisker',whiskerno);
set(h2,'LineWidth',5);
hold off
set(gca,'fontsize',30)
title ('(b)', 'FontSize',30)
xlabel('Severity Level for SpO_2', 'FontSize',30,'FontWeight','bold');
ylabel('Percentage of Minutes', 'FontSize',30,'FontWeight','bold');
legend([h1(5,1),h2(5,1),h3(5,1)],
{'COPD','Asthma','Healthy'},'FontSize',30,'AutoUpdate','off', 'Orientation',
'Horizontal')
set(gca,'YTick',0:10:100);
set(gca, 'XTickLabel',cstr);
color = repelem(['m', 'g', 'b'], 5);
h = findobj(gca,'Tag','Box');
for j=1:length(h)
patch(get(h(j),'XData'),get(h(j),'YData'),color(j),'FaceAlpha',.5);
end

(ii)

Figure 10

beta = [0.5 0.5];
Model_Results = models (beta);
be= Model_Results;
beta = [0.4 0.6];
Model_Results = models (beta);
bu= Model_Results;
Model_Results = [be bu];
%%%%%%%%%%%%
% Mean of Percentage of all COPD SpO2
mean_EOI_COPD = mean(Model_Results(1:85,:)); %mean COPD
sd_EOI_COPD= std (Model_Results(1:85,:)); %Standard Deviation COPD
% Mean of Percentage of all Asthma HR
mean_EOI_Asthma = mean(Model_Results(86:152,:)); %mean Asthma
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sd_EOI_Asthma = std (Model_Results(86:152,:)); %Standard Deviation Asthma
% Mean of Percentage of all Healthy HR
mean_EOI_Healthy = mean(Model_Results(153:158,:)); %mean Healthy
sd_EOI_Healthy = std (Model_Results(153:158,:)); %Standard Deviation Healthy
% COPD, Asthma and Healthy HR in a single plot
mean_COPD_Asthma_Healthy_HR = [mean_EOI_COPD ; mean_EOI_Asthma ;
mean_EOI_Healthy]; % mean vectors
std_COPD_Asthma_Healthy_HR = round([sd_EOI_COPD/sqrt(85) ;
sd_EOI_Asthma/sqrt(67) ; sd_EOI_Healthy/sqrt(16)],2); % standard deviation
of vectors
figure;
%mean_COPD_Asthma_Healthy_HR = [a(:,1) a(:,4) a(:,7) a(:,10) a(:,13) a(:,16)
a(:,19)];
%std_COPD_Asthma_Healthy_HR = [b(:,1) b(:,4) b(:,7) b(:,10) b(:,13) b(:,16)
b(:,19)];
hold on
hb = bar(1:4,mean_COPD_Asthma_Healthy_HR');
A = char (945);
B = char (946);
a = ['C';'T'];
b = ['E';'U'];
formatSpec = '%s_{%cM}%s_{%c}';
str1=
str2=
str3=
str4=

sprintf(formatSpec,A,a(1),B,b(1));
sprintf(formatSpec,A,a(2),B,b(1));
sprintf(formatSpec,A,a(1),B,b(2));
sprintf(formatSpec,A,a(2),B,b(2));

cstr = {str1, str2, str3, str4};
set(gca, 'XTickLabel',cstr, 'XTick',1:4*numel(cstr),'fontsize',25);
colormap([0 0 1;
%// blue
1 0 1;
%// magenta
0 1 0]);
%// green
%title('HR:SpO2:20:80 ', 'FontSize',10)
xlabel('Models', 'FontSize',30,'FontWeight','bold');
ylabel('Mean EOI', 'FontSize',30,'FontWeight','bold');
legend ({'COPD', 'Asthma', 'Healthy'},'FontSize',30,'AutoUpdate','off');
%ax = axes; xticklabels(ax,{ 'Low', 'Middle', 'High', 'A', 'B'});
% For each set of bars, find the centers of the bars, and write error bars
pause(0.1); %pause allows the figure to be created
for ib = 1:numel(hb)
%XData property is the tick labels/group centers; XOffset is the offset
%of each distinct group
xData = hb(ib).XData+hb(ib).XOffset;
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ee =
errorbar(xData,mean_COPD_Asthma_Healthy_HR(ib,:),std_COPD_Asthma_Healthy_HR(i
b,:),'k.','LineWidth',2);
end
ylim ([0 30])

(iii)

Figure 11

%Combination 2 beta and 2 alpha %%%%% copd
beta_all = [0.5 0.5;
0.4 0.6];
load matlab6;
%r = [percent_Values_HR_COPD; percent_Values_HR_Asthma;
percentValuesHRHealthy];
%p = [percent_Values_SP_COPD; percent_Values_SP_Asthma;
percentValuesSPHealthy];
%r = [percent_Values_HR_Asthma; percentValuesHRHealthy];
%p = [percent_Values_SP_Asthma; percentValuesSPHealthy];
r = [percent_Values_HR_COPD; percentValuesHRHealthy];
p = [percent_Values_SP_COPD; percentValuesSPHealthy];
h (1) = figure;
pt = ones(2,1);
Color = {'b','g';'m','r'}; % Cell array of colros.
A = ["Normal","Mild","Moderate","Severe","Very Severe"];
for s = 0:4
subplot (2,5,s+1)
for b = 1:2
beta = beta_all (b,:);
Model_Results = models (beta);
for j = 1:2
k = j + 2*(j-1);
x = Model_Results (:,k);
plfit = polyfit(x,r(:,s+1),1);
x1 = linspace(0,100);
y1 = polyval(plfit,x1);
pt(b) = plot(x1,y1, 'lineWidth',1.5,'color',Color{j,b});
hold on
end
set(gca,'fontsize',14);
set(gca,'XTick',0:25:100);
set(gca,'YTick',0:10:100);
xlim([0 100])
ylim ([0 100])
title({['Severity- ',num2str(s)];A(s+1)},'FontSize',15);
xlabel('EOI', 'FontSize',15,'FontWeight','bold');
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ylabel('Heart rate: Percentage of Minutes',
'FontSize',15,'FontWeight','bold');
end
if s==4
lgd = legend
({'\alpha_C_M,\beta_E','\alpha_T_M,\beta_E','\alpha_C_M,\beta_U','\alpha_T_M,
\beta_U'},'Location','best','FontSize',15,'AutoUpdate','on');
title(lgd,'Models')
end
end
for u = 1:5
subplot (2,5,u+5)
for b = 1:2
beta = beta_all (b,:);
Model_Results = models (beta);
for j = 1:2
k = j + 2*(j-1);
x = Model_Results (:,k);
plfit = polyfit(x,p(:,u),1);
x1 = linspace(0,100);
y1 = polyval(plfit,x1);
plot(x1,y1,'lineWidth',1,'color',Color{j,b})
hold on
end
set(gca,'fontsize',14);
set(gca,'XTick',0:25:100);
set(gca,'YTick',0:10:100);
xlim([0 100])
ylim ([0 100])
%title(['Severity ', num2str(u)], 'FontSize',15)
xlabel('EOI', 'FontSize',15,'FontWeight','bold');
ylabel('SpO_2: Percentage of Minutes', 'FontSize',15,'FontWeight','bold');
end
end

(iv)

Figure 12

load matlab6;
%%%% COPD %%%%
beta = [0.5 0.5];
Model_Results = models (beta);
be= Model_Results;
beta = [0.4 0.6];
Model_Results = models (beta);
bu= Model_Results;
Model_Results = [be bu];
j = 1; %COPD
x = Model_Results (j,1);
bb = round(Model_Results(j,:),2);
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subplot (2,2,1)
bar (bb)
A = char (945);
B = char (946);
a = ['C';'T'];
b = ['E';'U'];
formatSpec = '%s_{%cM}%s_{%c}';
str1=
str2=
str3=
str4=

sprintf(formatSpec,A,a(1),B,b(1));
sprintf(formatSpec,A,a(2),B,b(1));
sprintf(formatSpec,A,a(1),B,b(2));
sprintf(formatSpec,A,a(2),B,b(2));

%str = {['EOI=', num2str(x)]};
%text(1,90,str ,'FontSize',14,'EdgeColor', 'k')
dataLabels = {str1, str2, str3, str4};
ax = gca;
ax.XTick = 1:numel(dataLabels);
ax.XTickLabel = dataLabels;
ax.XLim = [0 numel(dataLabels)+1];
set(gca,'fontsize',20);
title ('COPD', 'fontsize',25)
ylabel ('EOI','fontsize',25)
ylim ([0 100])
set(gca,'YTick',0:10:100);
str = {['EOI = ', num2str(bb)]};
text(0.2,40,str ,'FontSize',17,'EdgeColor', 'k','FontWeight','bold')
%%% Healthy COPD %%%%
j = 90;
x = Model_Results (j,1);
bb = round(Model_Results(j,:),2);
subplot (2,2,3)
bar (bb, 'g')
A = char (945);
B = char (946);
a = ['C';'T'];
b = ['E';'U'];
formatSpec = '%s_{%cM}%s_{%c}';
str1= sprintf(formatSpec,A,a(1),B,b(1));
str2= sprintf(formatSpec,A,a(2),B,b(1));
str3= sprintf(formatSpec,A,a(1),B,b(2));
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str4= sprintf(formatSpec,A,a(2),B,b(2));
str = {['EOI = ', num2str(bb)]};
text(0.2,20,str ,'FontSize',17,'EdgeColor', 'k','FontWeight','bold')
dataLabels = {str1, str2, str3, str4};
ax = gca;
ax.XTick = 1:numel(dataLabels);
ax.XTickLabel = dataLabels;
ax.XLim = [0 numel(dataLabels)+1];
set(gca,'fontsize',20);
title ('Healthy', 'fontsize',25)
ylabel ('EOI','fontsize',25)
ylim ([0 100])
set(gca,'YTick',0:10:100);
%%%% Asthma %%%
beta = [0.5 0.5];
Model_Results = Asthmamodels (beta);
bea= Model_Results;
beta = [0.4 0.6];
Model_Results = Asthmamodels (beta);
bua= Model_Results;
Model_Results = [bea bua];
j = 2;
x = Model_Results (j,1);
bb = round(Model_Results(j,:),2);
subplot (2,2,2)
bar (bb, 'm')
A = char (945);
B = char (946);
a = ['C';'T'];
b = ['E';'U'];
formatSpec = '%s_{%cM}%s_{%c}';
str1=
str2=
str3=
str4=

sprintf(formatSpec,A,a(1),B,b(1));
sprintf(formatSpec,A,a(2),B,b(1));
sprintf(formatSpec,A,a(1),B,b(2));
sprintf(formatSpec,A,a(2),B,b(2));

str = {['EOI=', num2str(bb)]};
text(0.2,90,str ,'FontSize',17,'EdgeColor', 'k','FontWeight','bold')
dataLabels = {str1, str2, str3, str4};
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ax = gca;
ax.XTick = 1:numel(dataLabels);
ax.XTickLabel = dataLabels;
ax.XLim = [0 numel(dataLabels)+1];
set(gca,'fontsize',20);
title ('Asthma', 'fontsize',25)
ylabel ('EOI','fontsize',25)
ylim ([0 100])
set(gca,'YTick',0:10:100);
j = 72;
x = Model_Results (j,1);
bb = round(Model_Results(j,:),2);

subplot (2,2,4)
bar (bb, 'g')
A = char (945);
B = char (946);
a = ['C';'T'];
b = ['E';'U'];
formatSpec = '%s_{%cM}%s_{%c}';
str1=
str2=
str3=
str4=

sprintf(formatSpec,A,a(1),B,b(1));
sprintf(formatSpec,A,a(2),B,b(1));
sprintf(formatSpec,A,a(1),B,b(2));
sprintf(formatSpec,A,a(2),B,b(2));

str = {['EOI = ', num2str(bb)]};
text(0.2,20,str ,'FontSize',17,'EdgeColor', 'k','FontWeight','bold')
dataLabels = {str1, str2, str3, str4};
ax = gca;
ax.XTick = 1:numel(dataLabels);
ax.XTickLabel = dataLabels;
ax.XLim = [0 numel(dataLabels)+1];
set(gca,'fontsize',20);
title ('Healthy', 'fontsize',25)
ylabel ('EOI','fontsize',25)
ylim ([0 100])
set(gca,'YTick',0:10:100);

(v)

Figure 13, 14, 17, 19, 23 and 24

y = [47 43; 25 17;5 4;4 17;4 4];
bar (y)
leg = legend ({'Model', 'K-Means'});
title(leg,'COPD')
ylabel ('Number of Subjects')
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set (gca, 'fontsize',30)
cstr = {'Sev-0','Sev-1','Sev-2','Sev-3','Sev-4'};
set (gca, 'XTickLabel',cstr)
%
a = [15 17; 28 10;14 28;6 4;4 8];
bar (a)
leg = legend ({'Model', 'K-Means'});
title(leg,'Asthma')
ylabel ('Number of Subjects')
set (gca, 'fontsize',30)
cstr = {'Sev-0','Sev-1','Sev-2','Sev-3','Sev-4'};
set (gca, 'XTickLabel',cstr)
% Performance metrics
yy = [60 74 61 76; 79 49 76 45;100 100 100 100; 88 66 87 62; 100 100 100 100;
56 67 57 69; 80 89 81 90];
bar (yy)
leg = legend ({'\alpha_C_M\beta_E',
'\alpha_T_M\beta_E','\alpha_C_M\beta_U','\alpha_T_M\beta_U'});
title(leg,'COPD')
ylabel ('Percentage')
set (gca, 'fontsize',20)
cstr = {'Accuracy','Sensitivity','Specificity','F1','Precision',
'PPV','NPV'};
set (gca, 'XTickLabel',cstr)
%
aa = [52 60 51 60;94 78 96 77;83 100 83 100; 96 87 97 87;98 100 98 100;51 56
51 56;60 78 57 78];
bar (aa)
leg = legend ({'\alpha_C_M\beta_E',
'\alpha_T_M\beta_E','\alpha_C_M\beta_U','\alpha_T_M\beta_U'});
title(leg,'Asthma')
ylabel ('Percentage')
set (gca, 'fontsize',20)
cstr = {'Accuracy','Sensitivity','Specificity','F1','Precision',
'PPV','NPV'};
set (gca, 'XTickLabel',cstr)
% Model Distributions
c = [18 43 20 47;31 37 35 25 ;25 7 22 5;6 4 3 4;5 4 5 4];
bar (c)
leg = legend ({'\alpha_C_M\beta_E',
'\alpha_T_M\beta_E','\alpha_C_M\beta_U','\alpha_T_M\beta_U'});
title(leg,'COPD')
ylabel ('Number of Subjects')
set (gca, 'fontsize',30)
cstr = {'Sev-0','Sev-1','Sev-2','Sev-3','Sev-4'}
set (gca, 'XTickLabel',cstr)
%
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aaa = [4 15 3 15;15 28 15 27;25 14 23 14;13 6 15 6;10 4 11 4];
bar (aaa)
leg = legend ({'\alpha_C_M\beta_E',
'\alpha_T_M\beta_E','\alpha_C_M\beta_U','\alpha_T_M\beta_U'});
title(leg,'Asthma')
ylabel ('Number of Subjects')
set (gca, 'fontsize',30)
cstr = {'Sev-0','Sev-1','Sev-2','Sev-3','Sev-4'}
set (gca, 'XTickLabel',cstr)

(vi)

Figure 15 and 16

beta_all = [0.5 0.5;
0.4 0.6];
Marker = {'s','p','h'};
dispp = 0;
dispt = 0;
Sensitivity = ones(2,2);
Specifity = ones(2,2);
Accuracy= ones(2,2);
Precision = ones(2,2);
F1score = ones(2,2);
Level = ones(1,91);
EDGES = [0 1.5 9.5 29.5 49.5 100];
ppp = ones(2,2);
%%%%%% COPD %%%%%%%
class_1 = [ones(85,1);zeros(6,1)];
figure
for b = 1:2
beta = beta_all (b,:);
Model_Results = models (beta);
for j = 1:2
xx = Model_Results (:,j);
Level(xx<1.5) = 0;
Level(xx>=1.5) = 1;
C = categorical(Level,[0 1],{'Normal','Severe'});
Total = histcounts(C);%Histcounts
COPD = xx(1:85,1);
Healthy = xx(86:91,1);
edges = [0 1.5 100];
c = histcounts(COPD,edges);
FD_C = histcounts(COPD,EDGES); %All Severities
FD_h = histcounts(Healthy,EDGES) %All Severities
FN = c (1);
TP = c (2);
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h = histcounts(Healthy,edges);
TN = h(1);
FP = h(2);
Accuracy(j,b)= round((TP+TN/(TP+TN+FN+FP)),2);
Sensitivity (j,b)= 100*round(TP/(TP+FN),2); %TPR
Specifity (j,b)= 100*round(TN/(TN+FP),2); %
Precision (j,b)= 100*round(TP/(TP+FP),2);
F1score(j,b) = 100*round(2*TP/(2*TP+FP+FN),2);
%%%
class_2 = Level';
data = [class_1, class_2];
%%%%%
L = size(data,1);
% Data classes length
% Calculating the threshold values between the data points
s_data = unique(sort(data(:)));
% Sorted data points
d_data = diff(s_data);
% Difference between consecutive
points
if(isempty(d_data)), error('Both class data are the same!'); end
d_data(length(d_data)+1,1) = d_data(length(d_data));% Last point
thres(1,1) = s_data(1) - d_data(1);
% First point
thres(2:length(s_data)+1,1) = s_data + d_data./2; % Threshold values
% Sorting each class
if(mean(data(:,1))>mean(data(:,2))), data = [data(:,2),data(:,1)]; end
% Calculating the sensibility and specificity of each threshold
curve = zeros(size(thres,1),2);
distance = zeros(size(thres,1),1);
for id_t = 1:1:length(thres)
TP = length(find(data(:,2) >= thres(id_t)));
% True positives
FP = length(find(data(:,1) >= thres(id_t)));
% False positives
FN = L - TP;
% False negatives
TN = L - FP;
% True negatives
curve(id_t,1) = TP/(TP + FN);
curve(id_t,2) = TN/(TN + FP);

% Sensitivity
% Specificity

% Distance between each point and the optimum point (0,1)
distance(id_t)= sqrt((1-curve(id_t,1))^2+(curve(id_t,2)-1)^2);
end
% Optimum threshold and parameters
[~, opt] = min(distance);
TP = length(find(data(:,2) >= thres(opt)));
FP = length(find(data(:,1) >= thres(opt)));
FN = L - TP;
TN = L - FP;
param.Threshold = thres(opt);
% Optimum threshold position
param.Sensi = curve(opt,1);
% Optimum threshold's sensitivity
param.Speci = curve(opt,2);
% Optimum threshold's specificity
param.AROC = round(abs(trapz(1-curve(:,2), curve(:,1))),2); % Area under
curve
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param.Accuracy = round((TP+TN)/(TP+TN+FP+FN),2);
% Maximum
accuracy
param.PPV
= round(TP/(TP+FP),2);
% Positive predictive value
param.NPV
= round(TN/(TN+FN),2);
% Negative predictive value
% Plotting if required
if(dispp == 1)
%fill_color = [11/255, 208/255, 217/255];
%fill([1-curve(:,2); 1], [curve(:,1); 0],
fill_color,'FaceAlpha',0.5);
Color = {'b','g';'m','r'}; % Cell array of colros.
plot (0:1,0:1,'--k', 'LineWidth', 2)
hold on; ppp(j,b) = plot(1-curve(:,2), curve(:,1),'color',Color{j,b},
'LineWidth', 2);
hold on; plot(1-curve(opt,2), curve(opt,1), 'oc', 'MarkerSize', 10);
hold on; plot(1-curve(opt,2), curve(opt,1), 'xk', 'MarkerSize', 12);
xlabel('False Positive Rate (1 - Specificity)'); ylabel('True
Positive Rate (Sensitivity)');
%title(['AROC = ' num2str(param.AROC)]);
set(gca,'fontsize',30);
set(gca,'XTick',0:.1:1);
set(gca,'YTick',0:.1:1);
end
% Log screen parameters if required
if(dispt == 1)
display(' ------------------------------');
display('|
ROC CURVE PARAMETERS
|');
display(' ------------------------------');
display([' - Distance:
' num2str(distance(opt))]);
display([' - Threshold:
' num2str(param.Threshold)]);
display([' - Sensitivity: ' num2str(param.Sensi)]);
display([' - Specificity: ' num2str(param.Speci)]);
display([' - AROC:
' num2str(param.AROC)]);
display([' - Accuracy:
' num2str(param.Accuracy*100) '%']);
display([' - PPV:
' num2str(param.PPV*100) '%']);
display([' - NPV:
' num2str(param.NPV*100) '%']);
display(' ');
end
% Assinging parameters and curve data
ROC_data.param = param;
ROC_data.curve = curve;
%%%%%
hold on
end
end
lgdd = legend ([ppp(1,1) ppp(2,1) ppp(1,2)
ppp(2,2)],{'\alpha_C_M,\beta_E','\alpha_T_M,\beta_E','\alpha_C_M,\beta_U','\a
lpha_T_M,\beta_U'},'Location','best','FontSize',35,'AutoUpdate','off');
title(lgdd,'COPD');

(vii)

Figure 18 and 20
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%%%%%%%%%%%%%% Frequncy Distribution 2018 %%%%%%%%%%%%%%%%
b = 2; %1 or 2
j = 2; % 1 or 2
beta_all = [0.5 0.5;
0.4 0.6];
beta = beta_all (b,:); %b = 1 or 2
Model_Results = models (beta);
%k = j + 2*(j-1);
x = Model_Results (:,j);
figure
%subplot (1,2,1)
COPD = x(1:85,1);
Healthy = x(86:101,1);
[N1,edges1] = histcounts(COPD,'BinMethod','integers');%Histcounts
ph(1)= stem (0:100,N1,'b','lineWidth',5,'Marker','none');
hold on
[N3,edges3] = histcounts(Healthy,'BinMethod','integers');%Histcounts
ph(2)= stem (0:numel(N3)-1,N3,'pg','lineWidth',5,'Marker','none');
maxi = [max(N1), max(N3)];
maxx = max (maxi);
ylim ([0.1 maxx])
%xlim ([0 103])
set(gca,'fontsize',50)
set(gca,'XTick',0:10:100);
title ('(a) COPD:\alpha_T_M\beta_U', 'FontSize',55)
xlabel('EOI', 'FontSize',55);
ylabel('Number of Subjects', 'FontSize',55);
legend([ph(1) ph(2)],{'COPD',
'Healthy'},'FontSize',45,'Orientation','horizontal','AutoUpdate','off');
%%%Counting
edges = [0 1.5 9.5 29.5 49.5 100];
N = histcounts(COPD,edges);
vline1 = stem(edges(2), maxx); vline1.Color
vline2 = stem(edges(3), maxx); vline2.Color
set(vline2,'LineStyle','-.','LineWidth',5);
vline3 = stem(edges(4), maxx); vline3.Color
set(vline3,'LineStyle',':','LineWidth',5);
vline4 = stem(edges(5), maxx); vline4.Color
-','LineWidth',5);
ah=axes('position',get(gca,'position'),...
'visible','off');
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= 'y'; set(vline1,'LineWidth',5);
= [0.9100 0.4100 0.1700];
= [0.5430 0 0];
= 'k';

set(vline4,'LineStyle','-

legend(ah,[vline1 vline2 vline3 vline4],{'Mild', 'Moderate', 'Severe',
'Very Severe'} ,'Location','best','FontSize',45);
%legend ({'Mild', 'Moderate', 'Severe', 'Very
Severe'},'FontSize',30,'AutoUpdate','off');
%legend([vline1 vline2 vline3 vline4],{'Normal','Mild', 'Moderate', 'Severe'}
,'Location','best','FontSize',15,'Orientation','horizontal');
diff (edges)
sum (N)
max (edges3)
numel(N3)
%%% Asthma $$$
b = 1; %1 or 2
j = 2; % 1 or 2
beta_all = [0.5 0.5;
0.4 0.6];
beta = beta_all (b,:); %b = 1 or 2
Model_Results = Asthmamodels (beta);
%k = j + 2*(j-1);
x = Model_Results (:,j);
figure
%subplot (1,2,2)
Asthma = x(1:67,1);
Healthy = x(68:83,1);
hAx(1) = axes();
[N1,edges2] = histcounts(Asthma,'BinMethod','integers');%Histcounts
hLine(1) = stem (0:100,N1,'m','lineWidth',5,'Marker','none');
hold on
[N3,edges3] = histcounts(Healthy,'BinMethod','integers');%Histcounts
hLine(11) = stem (0:numel(N3)-1,N3,'g','lineWidth',5,'Marker','none');
maxi = [max(N1), max(N3)];
maxx = max (maxi);
ylim ([0.1 maxx])
legend ([hLine(1) hLine(11)],{'Asthma',
'Healthy'},'FontSize',45,'Orientation','horizontal','AutoUpdate','off');
%xlim ([0 103])
set(gca,'fontsize',50)
set(gca,'XTick',0:10:100);
title ('(b) Asthma:\alpha_T_M\beta_E', 'FontSize',55)
xlabel('EOI', 'FontSize',55);
ylabel('Number of Subjects', 'FontSize',55);
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%%%Counting
edges = [0 1.5 9.5 29.5 49.5 100];
N = histcounts(Asthma,edges)
vline1 = stem(edges(2), maxx); vline1.Color
vline2 = stem(edges(3), maxx); vline2.Color
set(vline2,'LineStyle','-.','LineWidth',5);
vline3 = stem(edges(4), maxx); vline3.Color
set(vline3,'LineStyle',':','LineWidth',5);
vline4 = stem(edges(5), maxx); vline4.Color
-','LineWidth',5);

= 'y'; set(vline1,'LineWidth',5);
= [ 0.9100 0.4100 0.1700];
= [0.5430 0 0] ;
= 'k';

set(vline4,'LineStyle','-

ah=axes('position',get(gca,'position'),...
'visible','off');
legend(ah,[vline1 vline2 vline3 vline4],{'Mild Intermittent', 'Mild
Persistent', 'Moderate Persistent', 'Severe Persistent'}
,'Location','best','FontSize',45);
%legend ({'Asthma', 'Healthy','Mild Intermittent', 'Mild Persistent',
'Moderate Persistent', 'Severe
Persistent'},'FontSize',30,'AutoUpdate','off');

E.

Clustering

(i)

Figure 21 and 22

R code
library(readr)
setwd("C:/Users/tsddiqui/OneDrive - The University of Memphis/Research R outputs")
As <- read_csv("C:/Users/tsddiqui/OneDrive - The University of Memphis/Research R outputs/Asthma.csv")
CC <- read_csv("C:/Users/tsddiqui/OneDrive - The University of Memphis/Research R outputs/COPD.csv")
#As<- read_csv("C:/Users/Tasnuba/OneDrive for Business/Research R outputs/Asthma.csv")
#CC <- read_csv("C:/Users/Tasnuba/OneDrive for Business/Research R outputs/COPD.csv")
A<-As[1:67,2:11]
cpd<-CC[1:85,2:11]
attach(A)
attach(cpd)
apply(A, 2, mean)
apply(A, 2, var)
pr.out=prcomp(A, scale=TRUE)
xx = pr.out$x [,1:2]
km.out=kmeans(A,5,nstart=45)
km.out$size # 17 10 28 4 8
CC= c("grey", "gold", "tomato","maroon","black")
pp = c(17, 19, 15, 18, 8)
CC= c("grey", "tomato", "gold","black","maroon") # Custom for COPD
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pp = c(17, 15, 19, 8, 18) # Custom for COPD
apply(cpd, 2, mean)
apply(cpd, 2, var)
cpr.out=prcomp(cpd, scale=TRUE)
cx = cpr.out$x [,1:2]
ckm.out=kmeans(cpd,5,nstart=45)
ckm.out$size # 43 17 4 17 4
par(mfrow=c(1,2))
# COPD
ci = ckm.out$cluster
cbp<-plot(cx, col=CC[ci], main="(a) COPD", adj = 0,xlab="Principal Component 1", ylab="Principal Component
2",
pch = pp[ci], cex=2, cex.main = 1.2, cex.lab = 1.4)
CC= c("maroon", "gold", "black","grey","tomato") # Custom for Asthma
pp = c(18,19,8,17,15) # Custom for Asthma
# Asthma
i = km.out$cluster
bp<-plot(xx, col=CC[i], main="(b) Asthma", adj = 0,xlab="Principal Component 1", ylab="Principal Component 2",
pch = pp[i], cex=2, cex.main = 1.2, cex.lab = 1.4)

# Legend 1
legend("top",legend=c("NOR","MIL","MOD","SEV","VES"), xjust = 0.5, yjust = 1,
border = "black",fill,col = c("grey", "gold", "tomato","maroon","black"),xpd = TRUE, horiz = TRUE, inset =
c(0,.09), bty = "o", pch = c(17, 19, 15, 18, 8),cex=1.2)
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